Registration Number: 333-100925
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SB-2
SECOND AMENDMENT TO
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
SPONGETECH DELIVERY SYSTEMS, INC.
---------------------------------
(Name of small business
issuer in its charter)
Delaware 2840 54-2077231
----------------------- ---------------------------- -------------------
(State of incorporation (Primary Standard Industrial (I.R.S. Employer
or jurisdiction Classification Code Number) Identification No.)
of organization)
Sunset Industrial Park, 50 20th Street, Brooklyn, New York 11232 (718) 788-4798
--------------------------------------------------------------------------------
(Address and telephone number of principal executive offices)
Sunset Industrial Park, 50 20th Street, Brooklyn, New York 11232 (718) 788-4798
--------------------------------------------------------------------------------
(Address of principal place of business or intended principal place of business)
Michael L. Metter, Spongetech Delivery Systems, Inc.
Sunset Industrial Park, 50 20th Street, Brooklyn, New York 11232 (718) 788-4798
--------------------------------------------------------------------------------
(Name, address, and telephone number of agent for service)
Copies to:
Joel Pensley, Esq.
211 Schoolhouse Road
Norfolk, Connecticut 06058
Phone: (860) 542-1122
Fax: (626) 608-3076
APPROXIMATE DATE OF PROPOSED SALE TO THE PUBLIC: From time to time after
the effective date of the registration statement until such time that all of the
shares of common stock registered hereunder have been sold.
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. /x/
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. / /
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
If delivery of the prospectus is expected to be made pursuant to Rule 434,
check the following box. / /
------------------------
CALCULATION OF REGISTRATION FEE
Proposed Proposed
Title of Maximum Maximum
Each Class of Amount Offering Aggregate Amount of
Securities Being Being Price Per Offering Registration
Registered Registered Share (1) Price(1) Fee
-------------------------------------------------------------------------------
Shares of common stock 4,485,000 $ 0.70 $ 3,139,500 $ 288.83
Shares of common stock
underlying stock
purchase agreement 4,000,000 $ 0.50 $ 2,000,000 184.00
------------- ----------
TOTAL $ 5,139,500 $ 472.83
(1) Estimated solely for the purposes of computing the registration fee
pursuant to Rule 457.
The registrant hereby amends the registration statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that the registration
statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933, as amended, or until the registration statement
shall become effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section 8(a), may determine.
ii
THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED.
THESE SECURITIES MAY NOT BE SOLD UNTIL THE REGISTRATION STATEMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THE PROSPECTUS IS NOT AN OFFER
TO SELL, NOR DOES IT SEEK AN OFFER TO BUY, THESE SECURITIES IN ANY STATE WHERE
THE OFFER OR SALE IS NOT PERMITTED.
Subject to completion: Dated April 10, 2003
PROSPECTUS
SPONGETECH DELIVERY SYSTEMS, INC.
8,485,000 SHARES OF COMMON STOCK
This prospectus relates to the resale by the selling stockholders of
4,485,000 shares of our common stock. None of our securities trades on any
securities market. Selling stockholders may sell their shares at $.70 per share
until a securities market quotes the shares. Thereafter, selling stockholders,
who are not affiliates, may sell their shares at market prices or at privately
negotiated prices. All the shares offered are currently outstanding. Selling
stockholders who are affiliates may sell their shares at $.70 per share for the
duration of the offering. We will not receive any of the proceeds from the sale
of the shares presently owned by the selling stockholders. We have paid, on
behalf of the selling stockholders, the expenses of the offering which we
estimate at $32,050.
In addition, we registering up to 4,000,000 shares for resale by Colebrook,
Inc. which may acquire up to 4,000,000 shares in a private placement under a
stock purchase agreement with us. In addition to being a selling stockholder,
Colebrook is considered to be an underwriter within the meaning of the
Securities Act of 1933 with respect to these shares.
Colebrook may sell our common stock at prices and on terms determined by
the market or in negotiated transactions. We will not receive any proceeds from
the sale of shares by Colebrook; however, we will receive proceeds from
Colebrook to the extent it acquires our common stock under the stock purchase
agreement. We are not required to sell any shares to Colebrook under the stock
purchase agreement, and we may decide not to do so. A description of the
agreement is found beginning on page xx of the prospectus.
Colebrook, Inc. may use this prospectus in connection with sales of up to
4,000,000 shares of our common stock.
We will not receive any of the proceeds from the sale of the shares by the
selling stockholders.
AS YOU REVIEW THE PROSPECTUS, YOU SHOULD CAREFULLY CONSIDER THE MATTERS
DESCRIBED IN "RISK FACTORS" BEGINNING ON PAGE 5.
THE INFORMATION IN THE PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THESE
SECURITIES MAY NOT BE SOLD UNTIL THE REGISTRATION STATEMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER
TO SELL, NOR DOES IT SEEK AN OFFER TO BUY, THESE SECURITIES IN ANY STATE WHERE
THE OFFER OR SALE IS NOT PERMITTED.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED ON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
The date of the prospectus is , 2003.
TABLE OF CONTENTS
PAGE
----
Prospectus Summary..................................................... 3
Information About ouf Stock Purchase Agreement with Colebrook.......... 3
The Offering........................................................... 4
Summary Financial Information.......................................... 5
Risk Factors........................................................... 6
Use of Proceeds........................................................ 9
Capitalization......................................................... 9
Dividend Policy........................................................ 9
Management's Discussion and Analysis of Financial Condition
and Results of Operations............................................. 10
Business............................................................... 12
Management............................................................. 15
Executive Officers and Directors...................................... 15
Director Compensation................................................. 16
Executive Compensation................................................ 16
Indemnification of directors and executive officers
and limitation of liability......................................... 18
Certain Related Party Transactions..................................... 18
Principal Stockholders................................................. 19
Description of Securities.............................................. 21
Common Stock.......................................................... 21
Preferred Stock....................................................... 21
Reports to Stockholders............................................... 22
Transfer Agent........................................................ 22
Selling Stockholders................................................... 22
Plan of Distribution of Shares of Existing Stockholders ............... 23
Stock Purchase Agreement............................................... xx
Colebrook's Plan of Distribution....................................... xx
Shares Eligible for Future Sale........................................ 26
Where You Can Find More Information.................................... 28
Legal Proceedings...................................................... 29
Legal Matters.......................................................... 29
Experts................................................................ 29
Index to Financial Statements.......................................... F-1
Financial Statements................................................... F-2
------------------------
You may rely only on the information contained in the prospectus. We have
not authorized anyone to provide information different from that contained in
this prospectus. Neither the delivery of this prospectus nor sale of common
stock means that information contained in the prospectus is correct after the
date of the prospectus. This prospectus is not an offer to sell or solicitation
of an offer to buy these shares of common stock in any circumstances under which
the offer or solicitation is unlawful.
2
PROSPECTUS SUMMARY
We design, produce, market and distribute cleaning products for vehicular
use utilizing patented technology relating to sponges containing hydrophilic,
which are liquid absorbing, foam polyurethane matrices. Our products can be
pre-loaded with detergents and waxes which are absorbed in the core of the
sponge then released gradually during use. We have also designed and have
started to test market, but have not yet produced or sold, products using the
same hydrophilic technology for bath and home use.
We were incorporated in New York State on June 18, 1999 under the name
Romantic Scents, Inc. We changed our name to RSI Enterprises, Inc. on June 12,
2001.
From our inception until December 2000, we, as Romantic Scents and RSI
Enterprises, were involved in the distribution of bath and beauty products. We
decided to leave the bath and beauty product business to focus on the
development and sale of cleaning products based on hydrophilic sponges.
As part of a plan of recapitalization and funding, we undertook a series of
steps:
o On July 15, 2002, we, as RSI Enterprises, entered into a stock purchase
agreement with Nexgen Acquisitions VIII, Inc. under which our sole
stockholder, RM Enterprises International, received 12,000,000 shares of
Nexgen Acquisitions VIII, Inc. and thereby became its majority stockholder.
Nexgen Acquisitions VIII, Inc. changed its name to Spongetech Delivery
Systems, Inc. on October 9, 2002.
o On December 16, 2002, we changed our domicile to Delaware.
o On December 16, 2002, Spongetech Delivery Systems, Inc. (formerly Nexgen
Acquisitions VIII, Inc.) merged with and into us so that we became the
surviving company. Immediately subsequent to the merger, we changed our
name to Spongetech Delivery Systems, Inc.
o On December 26, 2002, we, as Spongetech Delivery Systems, Inc., entered
into a securities purchase agreement with Colebrook, Inc.
INFORMATION ABOUT OUR STOCK PURCHASE AGREEMENT WITH NEXGEN HOLDINGS
We have entered into a stock puchase agreement with Colebrook to raise up
to $2 million through a series of sales of our common stock. The dollar amount
of each sale is limited by our common stock's price and a minimum period of time
that must elapse between each sale. Each sale will be to Colebrook. In turn,
Colebrook will either hold our stock in its own portfolio, sell our stock in the
open market, or place our stock through negotiated transactions with other
investors. The prospectus covers the resale of our stock by Colebrook either in
the open market or to other investors.
The stock purchase agreement provides that from time to time, upon our
providing written notice but not more often than every seven trading days, over
a two year period following the date our stock commences trading, Colebrook will
purchase our common stock from us. We decide, in our sole discretion (without
any penalties for non-use), whether and the extent to which we wish to require
Colebrook to purchase our common stock. We choose the dates and the number of
shares we sell to Colebrook. Colebrook is receiving no compensation from us
whatsoever whether or not in the nature of commissions, warrants , options or
termination fees.
3
We may sell between $25,000 and $50,000 of our common stock, each time, at
70% of the average closing bid price for the five trading days preceding the
notice of our intention to sell our stock. In order for us to sell our shares to
Colebrook, the trading volume for the five preceding days must average at least
25,000 shares per day. Colebrook may not purchase our shares of common stock if,
at the conclusion of any purchase, it would hold in excess of 9.9% of our issued
and outstanding common stock. We intend to use proceeds of stock sales to
Colebrook for working capital.
Our agreement with Colebrook is not a convertible debenture, convertible
preferred stock, or similar type of investment instrument. In addition, we are
not borrowing from Colebrook as with a conventional cash line of credit.
Our executive officers are located at: Sunset Industrial Park, 50 20th
Street, Brooklyn, New York 11232; and our telephone number at that address is
(718) 788-4798.
THE OFFERING
Common stock outstanding.......... 18,985,000 shares
Shares offered by the selling
stockholders who are holders
of their shares as of the date
of the prospectus.............. 4,485,000 shares of common stock
Selling stockholder under
stock purchase agreement....... Colebrook, Inc.
Shares offered pursuant to
stock purchase agreement....... A maximum of 4,000,000 shares of common stock
Offering Price of Shares......... The shares underlying the stock purchase
agreement, the resale of which are being
registered hereunder, are being offered to
Colebrook from time to time at 70% of the
then current market price.
Common stock to be outstanding
after the offering pursuant
to the stock purchase
agreement.................... 22,985,000 shares of common stock.
Pursuant to the terms of the stock purchase
agreement with Colebrook, we are not obli-
gated to sell any of our shares, unless it is
beneficial to us.
Use of proceeds................. The selling stockholders will receive the net
proceeds and we will receive none of the pro-
ceeds from the sale of the shares offered by
the prospectus. The proceeds of shares sold
to the investor pursuant to the securities
purchase agreement shall be used for working
capital.
4
SUMMARY FINANCIAL INFORMATION
The following table sets forth our summary consolidated financial data as
of May 31, 2002 and November 30, 2002 and for the years ended May 31, 2002 and
2001, and for the six months ended November 30, 2002 and 2001, which are derived
from the Company's financial statements.
Statement of Operations
Six Months Ended
November 30, Year Ended May 31,
2002 2001 2002 2001
------ ------ ------ ------
(unaudited) (unaudited)
----------- -----------
Sales $ 13,223 $ 33,887 $ 89,973 $ 11,790
Cost of goods sold 4,164 57,981 121,643 31,683
--------- ---------- --------- ----------
Gross profit (loss) 9,059 (24,094) (31,670) (19,893)
Operating expenses 99,134 54,199 70,407 177,997
--------- ---------- --------- ----------
Loss before income taxes (90,075) (78,293) (102,077) (197,890)
Income taxes 400 373 400 428
--------- ---------- --------- ----------
Net loss $ (90,475) $ (78,666) $ (102,477) $ (198,318)
========= ========== ========= ==========
Net loss per share -
Basic and diluted $ (.01) $ (.01) $ (.01) $ (.02)
========= ========== ========= ==========
Weighted average common
shares outstanding 17,267,377 12,000,000 12,000,000 12,000,000
========= ========== ========= ==========
November 30, 2002 May 31, 2002
----------------- ------------
unaudited
---------
Balance sheet data:
Total assets $ 119,517 $ 89,633
Total liabilities 314,554 238,585
Shareholders' equity (deficiency) (195,037) (148,952)
5
RISK FACTORS
You should carefully consider the following factors in addition to the
other information in this prospectus, including the financial statements and
related notes, before investing in the common stock. These risk factors are all
those which we believe are material to our business. Risks and uncertainties
that we do not presently know about or that we currently believe are immaterial
may also impair our business. If any of the following risks actually occurs, our
business, financial condition or results of operations will most likely suffer.
In such case, the trading price of our common stock could decline; and you could
lose all or part of your investment.
If we do not raise additional financing, there is a high risk that our business
will fail.
--------------------------------------------------------------------------------
We have suffered losses since our inception, have a significant
stockholders' equity deficiency, have minimal cash, have a working capital
deficiency and have only recently concluded our first material purchase orders.
If financing is not available or obtainable, our investors may lose a
substantial portion or all of their investment and our business may fail. We
have entered into a stock purchase agreement with an investor. However, we can
offer no assurance that we will be able to sell any stock pursuant to that
agreement to solve our financing needs. Consequently, we can provide no
assurance that additional financing, when necessary, will be available at all,
or if available, on acceptable terms. We have arranged for purchase order
financing for our orders with Turtle Wax. However, there is no assurance that
the finance company will advance funds for future purchase orders with Turtle
Wax or any other purchaser of our products. If we fail to raise additional
funds, we will may unable to fulfill orders, market our products, or make molds
for new products; and as a result our business may fail.
Our auditors have questioned our ability to continue as a going concern.
------------------------------------------------------------------------
Our independent auditor's report letter which accompanies our financial
statements states that our recurring net losses, working capital deficiency and
stockholders' equity deficiency raise substantial doubt about our ability to
continue as a going concern. If we are unable to increase our revenues while
containing costs, or decreasing costs while maintaining revenues or raising
substantial funds from third parties, we will be unable to continue as a going
concern and will be forced to suspend operations.
The market place may be indifferent to our products.
----------------------------------------------------
Our hydrophilic sponge, and products based on it, feature an internal
structure which holds detergents and waxes which are released only in use.
Potential users may be satisfied with the cleaners, waxes and applicators they
are presently using. Thus, we may expend our financial and personnel resources
on design, marketing and advertising without generating concomitant revenues.
We presently depend on one customer for almost all of our sales.
----------------------------------------------------------------
We have received two purchase orders for the supply of our automobile wash
and wax product to Turtle Wax. Although we are exploring and marketing our
product in other marketing channels for our automobile cleanser and wax product
and our child's bath and our home cleaning products, these channels have
generated little revenues to date for our automobile product and no revenues for
our other products and we can offer no assurance that they will ever be
commercially viable. In the event we cannot deliver or orders to Turtle Wax in
the quantity or of the quality desired or Turtle Wax does not enter into new
purchase orders after the completion of the existing orders, we may have no
existing business nor prospects for new business.
6
We depend on products made using one technology.
------------------------------------------------
Our automobile cleaning and waxing product, our child's bath product and
the household cleaning products depend on the use of licensed technology
relating to sponges incorporating a hydrophilic (liquid absorbing) polyurethane
matrix. A number of factors could limit our sales of these products, or the
profitability of such sales, including competitive efforts by other
manufacturers of similar products, shifts in consumer preferences or
introduction and acceptance of alternative product offerings. We have developed
no other products using other technologies and thus if our existing products or
others based on the same technology fail in the marketplace, our business would
fail.
Our license is limited to products for cleaning vehicles.
---------------------------------------------------------
Our license agreement with Dicon is limited to hydophilic sponges used to
clean and polish land, sea and air transportation vehicles. Our business plan
calls for us to expand our product line using hydrophilic sponges to areas of
personal hygiene and household cleaning. We have no assurance that Dicon will
expand our exclusive license to include the products we plan on developing and
marketing. If Dicon refuses to expand our license, we will be unable to expand
into these areas and our growth will be limited.
The patents on our licensed technology may not be able to be defended against
infringement.
--------------------------------------------------------------------------------
In the event a competitor uses our licensed technology, our licensor may
not be able successfully to assert patent infringement claims. In that event, we
may encounter direct competition using the same technology on which our products
are based and may not be able to compete.
We depend on one manufacturer for all our products.
---------------------------------------------------
Our licensor is also our manufacturer. Our reliance on a sole supplier
involves several risks, including our potential inability to obtain adequate
supplies and reduced control over pricing and timely delivery. Although the
timeliness, quality and pricing of deliveries from our licensor has been
acceptable to date there can be no assurance that supplies will be available on
an acceptable basis or that delays in obtaining new suppliers will not have an
adverse effect. Our inability to obtain adequate supplies of hydrophilic
sponges, chemicals, packaging materials, or finished products would prevent us
from fulfilling orders.
Our stock may not be able to trade on the Over-the-Counter Bulletin Board or,
when and if established, the Bulletin Board Exchange.
--------------------------------------------------------------------------------
We intend that our securities trade on the Over-the-Counter Bulletin Board.
However, we can offer no assurance that our securities will so trade and, if
they do trade on the OTCBB, whether an active trading market will be established
or, if established, whether it can be maintained. The National Association of
Securities Dealers, Inc. has announced the formation of a new automated
marketplace, the Bulletin Board Exchange, and the eventual dissolution of the
OTCBB. We can offer no assurance that our securities will be accepted on the
BBX, if established, and, if they do not, our securities may trade on the Pink
Sheets, a non-automated market with a consequential lack of liquidity.
7
An active market for our common stock may not develop, making it difficult for
you to sell your stock and preventing us from raising money through our stock
purchase agreement.
--------------------------------------------------------------------------------
Prior to the date of the prospectus, there has been no public market for
our common stock. It is uncertain the extent to which a trading market will
develop or how liquid that market might become. An illiquid market for our stock
may result in price volatility and poor execution of buy and sell orders for
investors. Historically, stock prices and trading volumes for newly public
companies fluctuate widely for a number of reasons, including some reasons that
may be unrelated to their business or results of operations. The price of our
common stock may be low and our volume below that which we need to sell our
stock to the investor pursuant to the stock purchase agreement stock. Thus, the
possibility of funding our ongoing operations will ceease in the event an active
trading market does not develop.
We may be unable to obtain sufficient funds from the stock purchase agreement
with Colebrook to meet our liquidity needs.
--------------------------------------------------------------------------------
When we desire to obtain funds for our business through the stock purchase
agreement with Colebrook, the volume of trading may too low to sell stock to
Colebrook,, or the market price of our stock may result in unacceptable dilution
or any sale may result in Colebrook's owning more than 9.9% of our issued and
outstanding common stock which would prohibit us from selling our stock to
Colebrook. As a result, we may be unable to obtain any or sufficient funds from
Colebrook to meet our financial needs. Thus, we will not be able to expand our
business.
The exercise of our rights to sell our common stock may substantially dilute the
interests of other security holders.
--------------------------------------------------------------------------------
We will issue shares to Colebrook upon exercise of our rights to sell our
common stock under the stock purchase agreement at a price equal to 70% of the
average closing bid price for the five days preceding the date we give notice of
our intention to exercise any put. Accordingly, the sale of our stock to
Colebrook under the stock purchase agreement may result in substantial dilution
to other holders of our common stock. Depending on the price per share of our
common stock, we may need to register additional shares for resale to access the
full amount of financing available. Registering additional shares could have a
further dilutive effect on the value of our common stock. If we are unable to
register the additional shares of common stock, we may experience delays in, or
be unable to, access some of the $2 million available under the stock purchase
agreement. nward pressure on the price of our common stock.
The sale of material amounts of our common stock could reduce the price of our
common stock and encourage short sales.
--------------------------------------------------------------------------------
If and when we exercise our put rights and sell shares of our common stock
to the investor and if and to the extent that the investor sells the common
stock, our common stock price may decrease due to the additional shares in the
market. If the price of our common stock decreases, and if we decide to exercise
our right to put shares to Colebrook, we must issue more shares of our common
stock for any given dollar amount received. Stock issuances may encourage short
sales, which could place further downward pressure on the price of our common
stock.
8
USE OF PROCEEDS
We will not receive any proceeds from the sale of the stockholders' shares
offered by this prospectus. All proceeds from the sale of the stockholders'
shares will be for the accounts of the selling stockholders. Proceeds, if any,
from the sale of stock pursuant to the stock purchase agreement will be used for
working capital.
CAPITALIZATION
The following table sets forth our capitalization as of November 30, 2002.
November 30,
2002
-----------
(Unaudited)
Long-term debt (related party) $ 80,570
---------
Shareholders' equity:
Common stock $.001 par value;
authorized 50,000,000 shares; issued
and outstanding 18,985,000 shares 18,985
Preferred stock, $.001 par value;
authorized 5,000,000 shares;
no shares issued and outstanding -
Additional paid in capital 229,448
Deficit (443,470)
---------
Total shareholders' equity (deficiency) (195,037)
---------
Total capitalization $ (114,467)
=========
Dividend Policy
---------------
We have not declared or paid any cash dividends on our common stock and do
not anticipate paying any cash dividends in the foreseeable future.
9
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
FOR THE YEARS ENDED MAY 31, 2002 AND MAY 31, 2001
AND THE SIX MONTH ENDED NOVEMBER 30, 2002 AND NOVEMBER 30, 2001
Management's Discussion and Analysis of Financial Condition and Results of
Operations
--------------------------------------------------------------------------------
The following discussion includes forward-looking statements with respect
to our future financial performance. These forward-looking statements are
subject to various risks and uncertainties, including the factors described in
the section titled Risk factors and elsewhere in this prospectus, that could
cause actual results to differ materially from historical results or those
currently anticipated. You should read the following discussion together with
the consolidated financial statements and their accompanying notes, included
elsewhere in this prospectus.
General
-------
Spongetech Delivery Systems, Inc. (formerly known as Nexgen Acquisitions
VIII, Inc.) was incorporated in January 2002 and was inactive until on July 15,
2002 it acquired all of the outstanding shares of Spongetech International, Ltd.
(formerly RSI Enterprises, Inc. and Romantic Scents, Inc.). The financial
statements as of May 31, 2002 and the related statements of operations, changes
in shareholders' equity (deficiency), and cash flows for the years ended May 31,
2002 and 2001 are of Spongetech International, Ltd.
The Company distributes a line of hydrophilic polyurethane sponge cleaning
and polishing products.
Results of Operations
---------------------
Six Months Ended November 30, 2002 and 2001 (unaudited)
-------------------------------------------------------
Net sales for the six months ended November 30, 2002 were $13,223 as
compared to $33,887 for 2001, a decrease of $20,664 or 61%. Management
attributes this decrease to cash flow constraints, which interrupted the
Company's marketing efforts. The Company's gross profit for the six months ended
November 30, 2002 was $9,059 or 68.5% as compared to ($24,094) or (71.1%).
Management attributes this increase to certain one time tooling charges
associated with new sponge products and expensing of mold costs in 2001, which
were ultimately not used in production.
Operating expenses for the six months ended November 30, 2002 were $99,134
or 750% of net sales as compared to $54,199 or 160% of net sales. For the six
months ended November 30, 2002 as compared to the same period of the prior year,
operating expenses increased in dollars by $44,935. This increase is a result of
a decrease in advertising and selling related travel of approximately $12,000
and increases in professional fees of approximately $15,000, depreciation of
approximately $2,000, interest of approximately $1,000 and officers compensation
of $39,000.
10
Net loss for the six months ended November 30, 2002 was ($90,475) or ($.01)
per share as compared to ($78,666) or ($.01) per share. The explanation of these
decreases can be derived from the analysis given above of operations for the six
month periods ending November 30, 2002 and 2001, respectively.
Years Ended May 31, 2002 and 2001
---------------------------------
Net sales increased by $78,183 or 663% from $11,790 for the year ended May
31, 2001 as compared to $89,973 for the year ended May 31, 2002. This increase
is primarily attributed to the establishment of additional products and the
marketing efforts of the prior year. The Company posted gross losses of $31,670
or 35.2% of net sales and $19,893 or 168.7% of net sales for the years ended May
31, 2002 and 2001, respectively. These gross losses were attributed to one time
tooling charges associated with the development of new sponge products and
expensing of mold costs which were ultimately not used in production.
Operating expenses for the year ended May 31, 2002 were $70,407 or 78.3% of
net sales as compared to $177,997 or 1,510% of net sales for the year ended May
31, 2001. For the year ended May 31, 2002 as compared to the prior year
operating expenses decreased in dollars by $107,590. This decrease was a result
of reductions in advertising and trade show costs aggregating approximately
$35,000, rent, consulting services and public relations cost of approximately
$72,000 and an increase in interest expense of approximately $2,000. Net loss
for the year ended May 31, 2002 was $102,477 or $.01 per share as compared to
net loss of $198,318 or $.02 per share. The decrease in net loss of $95,841 is
the result of the items mentioned above.
Liquidity and Capital Resources
-------------------------------
The Company had cash of $3,171 at November 30, 2002. During the six months
ended November 30, 2002, net cash provided by operating activities aggregated
$32,346. Net cash used in investing activities during the six months ended
November 30, 2002 aggregated $14,350 for the purchase of product molds.
Net cash used in financing activities for the six months ended November 30,
2002 aggregated $15,000 for accounting fees treated as deferred offering costs.
During the year ended May 31, 2002, net cash used in operating activities
aggregated $43,285 as compared to $115,896 used in the year ended May 31, 2001.
This decrease in the amount of cash used in operating activities is primarily
attributed to the decrease in net loss for the year ended May 31, 2002 as
compared to the net loss for the year ended May 31, 2001.
Net cash used in investing activities during the year ended May 31, 2002
aggregated $33,540, as compared to $14,900 used in the year ended May 31, 2001.
This increase is attributed to the purchasing of office equipment of
approximately $10,000 and additional purchases of product molds aggregating
approximately $23,000.
Net cash provided by financing activities for the year ended May 31, 2002
was $76,943 as compared to $130,100 during the year ended May 31, 2001. This
decrease is primarily attributed to a reduction in the support from Spongetech
International, Ltd.'s prior parent and no additional notes payable incurred
during the year ended May 31, 2002.
11
On December 26, 2002, the Company entered into a securities purchase
agreement. The agreement entitles Spongetech to issue up to $2 million of its
common stock from time to time, in blocks of between $25,000 to $50,000 each, at
a price per share calculated by a formula based on Spongetech's stock price. The
securities purchase agreement terminates two years following the effective date
of the registration of the shares. Proceeds of stock sales will be used for
working capital.
Liquidity and Capital Resources
The Company has negotiated with a factor a financing agreement to cover
customer purchase orders and subsequent accounts receivables and has received
monies from the factor secured by purchase orders and accounts receivable.
The working capital (deficiency) at November 30, 2002 was approximately
($181,000) as compared to the working capital (deficiency) of approximately
($110,000) at May 31, 2002. Total liabilities exceed total assets by
approximately $195,000 and $149,000 as of November 30, 2002 and May 31, 2002,
respectively. These factors create substantial doubt about the Company's ability
to continue as a going concern. The recovery of assets and the continuation of
future operations are dependent upon the Company's ability to obtain additional
debt or equity financing and its ability to generate revenues sufficient to
continue pursuing its business purpose.
The Company cannot guarantee that the results from operations will be
sufficient to support the Company's liquidity requirements through November 30,
2003 and beyond. There can be no assurances that the above actions will be
accomplished or whether they will be adequate.
Subsequent Events
-----------------
On December 16, 2002, Spongetech Delivery Systems, Inc. (formerly Nexgen
Acquisitions VIII, Inc.) merged with and into us so that we became the surviving
company. Immediately subsequent to the merger, we changed our name to Spongetech
Delivery Systems, Inc.
BUSINESS
Our Company
-----------
We design, produce, market and distribute cleaning products for vehicular
and home use utilizing patented technology relating to hydrophilic (liquid
absorbent) foam polyurethane matrices.
The Technology
--------------
We, as RSI Enterprises, Ltd., entered into a license agreement on July 1,
2001 on patented technology relating to hydrophilic polyurethane matrices on an
exclusive basis. The technology is owned by and is licensed from from H. H.
Brown Shoe Technologies, Inc., Greenwich, CT., (dba Dicon Technologies), a
majority-owned subsidiary of Berkshire Hathaway, Inc. which owns the patent
rights. Our license applies to the cleaning and polishing of land, sea and air
transportation vehicles. We have oral understanding but no written agreements
with Dicon which would permit us to develop products using the same spone
technology in household cleaning and personal care and other areas in additional
to transportation vehicles.
Our license is a continuing one for the full life of the design patent,
which was jointly developed by one of our former employees, which covers the
design, manufacture and use of a liquid-absorbent layer in a "molded sponge
design." The patent expires in 2017.
The license agreement mandates that we purchase our hydorphilic sponge
products from Dicon unless Dicon ceases its business operations, either totally
or with respect to the manufacture of the Molded Sponge Design within the scope
of the Design Invention. In that event, we are permitted to use other
manufacturers.
12
Pursuant to the license agreement, Dicon retains title to the technology;
thus, if the license expires, we have given up design rights to products we
develop using the licensed technology. Dicon pays all expenses in connection
with the filing and maintaining of the patent. Certain minimum quantities of
production, as set forth in a requirements agreement with Dicon are needed to
continue the license. Dicon has the right, without restriction, to license its
technology in areas other than sponges.
The technology is also used to draw fluids out of a human body, such as
body odors, and store them in the polyurethane matrix. Shoe liners, incontinent
pads and nursing pads were originally contemplated as product embodiments of the
technology. Companies such as Payless Shoes and H. H. Brown Shoe Company (the
licensor) use the technology for inner soles to absorb sweat and odors. Revlon
is a licensee of the technology which it uses in a cosmetic make-up removal
product.
Our license is based on the discovery that if a sponge incorporating the
hydrophilic matrix is be filled with detergents and waxes, the matrix would
retain these cleaning and polishing agents which would only be released when the
sponge was squeezed. Thus, soap or wax could be retained for many uses and the
sponge could be rinsed after use without losing the cleaning agent or wax.
Supply and Requirements Agreement
----------------------------------
Also on July 1, 2002, we entered into an exclusive worldwide supply and
requirements agreement with Dicon under which we must purchase from Dicon
certain minimum quantities of our sponges containing the Dicon hydrophilic
matrix as follows:
Annual Period Number of Sponge Products
------------- -------------------------
1st annual period 250,000
2nd annual period 500,000
and each succeeding
annual period 1,000,000
at the following prices:
Aggregate Purchases Price per spong product
------------------- ----------------------
50,000 to 100,000 $.817 sponge only
100,000 to 250,000 $.795 sponge only
Over 250,000 $.778 sponge only
In the event the minimum quantities are not ordered, we must pay Dicon
liquidated damages of $.20 per sponge for the deficiency. If we fail to pay the
damages promptly, our license becomes non-exclusive for subsequent periods.
Dicon may, after the first annual period, raise the prices it charges only if
such increase is based bona fide increases for material and labor plus an
appropriate markup for overhead. The agreement expires at the end of the third
annual period. However, we may renew renew for additional successive periods. We
may use other manufacturers in the event of a breach by Dicon or in the event of
force majeure which prevents production for 90 days.
13
Dicon has designed and installed specialized equipment for producing molded
foam products containing this superabsorbent polymer infused with detergents,
soaps and waxes used as an absorbing and cleaning sponge product. The agreement
sets forth minimum purchase requirements and pricing for the basic sponge
product. Using its patented processes, Dicon manufactures products derives from
"Hydrophilic Urethane Chemistry." The hydrophilic system has two parts, a
hydrophilic pre-polymer phase and a water phase. During this water phase,
various water soluble active ingredients are introduced into the products.
We are the assignee of a manufacturers representative agreement with Dicon
which was originally entered into by R M Enterprises our majority stockholder.
Pursuant to this agreement, we may introduce customers for additional
hydrophilic foam products directly on a commission basis.
Products
--------
We have designed specially configured sponges containing an outer contact
layer and an inner matrix. Dicon, our licensor and manufacturer, loads the inner
matrix of the sponge with especially formulated soaps and, in our licensed
automotive cleaning and polishing product, soap and wax. When the sponge is
applied to a surface with minimal pressure, the soap or soap and wax are
simultaneously applied to the surface. When the sponge is not in use, the
hydrophilic matrix holds the soap so that it does not leech out of the sponge.
We believe that our use of the patent has great marketing potential. We can
choose any variety of cleansers, including anti-bacterial and abrasive soaps.
Thus, we may fine-tune our products for use on different kinds of vehicles. New
vehicles or those prepared for classic car shows require a gentle cleaner,
whereas older cars which have developed a film over the paint or where the paint
has faded may require a cleanser containing a compounding substance, a gentle
abrasive. Depending on the use of our vehicular sponge, we may include a wax, or
may only include the cleanser.
Sales and Marketing
-------------------
On September 17, 2002, we were issued a purchase order from Turtle Wax for
our private label auto applicator and appropriate packaging containing the words
"Turtle Wax Zip Wax" and the Turtle Wax logo imprint as part of the sponge
itself. The total amount of the first purchase order was $62,475 which was
shipped during January through March 2003. Subsequently, we have received
additional purchase orders from Turtle Wax aggregating $239,534 and have shipped
$154,780 of them leaving open orders of $84,854 which will be shipped
periodically during April and May, 2003 on a schedule set by Turtle Wax.
We have shipped to Home Shopping Network under the brand "Spongetech"
merchandise priced at $1,020. We have received additional purchase orders from
Home Shopping Network of $25,500 to be shipped on or before May 12, 2003.
We have also inaugurated in December 2002 an advertising program on the
radio program "Business Talk Radio" on the Jeff Brooks Show "On the Road." This
is a call-in nationally syndicated radio program on automobiles and related
products. Advertising is directed to our website (www.spongetech.com) and to our
toll-free number. We have retained a telemarketing company to take orders and
use a fulfillment house to pack and ship orders to customers. We pay the radio
station on a per item sold basis. We have not received significant orders from
this radio program and can give no assurances that it will become a successful
marketing channel.
14
We have entered into agreements with two distributors, one in the midwest
and one on the west coast. Their representatives visit and resell our automobile
sponge products to auto accessories stores - both independently-owned and chains
under the "Spongetech" brand name. We ship periodically to them. We have not
received significant orders from these distributors.
We have started selling our automotive sponge to a product marketer - a
logo and special message product company - which places unique promotional
advertising messages on our products for its customers. We have received
purchase orders which have aggregated, as of the date of this prospectus, 300
units containing the logo of businesses including a local bank and an automobile
dealership.
We have developed a children's bath foam sponge, with a "safe mesh" coating
which prevents tearing, in the shape of animals in various colors. The sponges,
which float, are infused with a gentle no-tear, non-irritating anti-bacterial
soap. The bath foam sponge does not lose its soap while it is floating in the
bath tub as the soap is retained by the inner hydrophilic matrix until the child
squeezes the sponge in use.
We are developing retail outlets to sell this product, ranging from
pharmacies to department stores. We intend to market directly. Dicon will
manufacture this product for us. We have not yet made sales and cannot offer any
assurances that sales will result from our proposed marketing campaign.
We have developed household cleaning sponges infused with anti-bacterial
bath and kitchen soaps. The products are being testing by a national detergent
manufacturer for possible use under its logo and brand. We cannot predict
whether or not the manufacturer will purchase our sponges and, if it does,
whether the product will succeed in the marketplace.
Dicon has produced samples for us of our children's bath foam sponge and
household cleaning sponge.
New Product Development
-----------------------
Our new product development program consists principally of devising or
testing new products, improving the efficiency of existing ones, evaluating the
environmental compatibility of products and market testing. We estimate that our
management devoted 2,000 man hours to developing the product, packaging and
marketing. We did not pay cash compensation for product development activities.
Facilities
----------
Our corporate headquarters are located in an industrial park in Brooklyn,
New York where we share 2,000 square feet of equipped office space and 10,000
square feet of warehouse space with other companies affiliated with our major
shareholder. Expenses incurred in the operations of the facility, including
rent, telephone, and other office expenses, are allocated to us based on our
usage.
15
Employees
---------
We currently employ five people of whom three are business and sales
management, and the remainder staff.
Competition
-----------
We compete with international, national and local manufacturers and
distributors of soaps, detergents, waxes, sponges, cloths and other automotive,
household and bath products. Indirectly, in the automotive product area, we
compete with drive-through auto washes. Our competition, for the most part, has
brand recognition and large marketing and advertising budgets. Many competing
products are less expensive than ours to the consumer. We face major
multinational competition in our proposed household and children's bath product.
Although our product is unique and patented, we cannot predict its acceptance in
any of the marketplace for which they are designed.
MANAGEMENT
Executive Officers and Directors
--------------------------------
The following table sets forth certain information regarding our executive
officers and directors:
Name Age Position Since
------------------------ --- ------------- ---------
Michael Metter* 51 President
One Tinker Lane Chief Executive Officer
Greenwich, CT 06830 and a Director 5/2001
Steven Moskowitz* 38 Secretary
50 20th Street and a Director 6/1999
Brooklyn, New York 11232
Jerome Schlanger 46 Treasurer
50 20th Street and a Director 6/1999
Brooklyn, New York 11232
Frank Lazauskas 42 A Director 7/2001
51 Niagara Street
Newark, New Jersey 07105
Roger Eichenholtz 59 Chief Financial Officer
50 20th Street Chief Accounting Officer 8/2000
Brooklyn, New York 11232
----------------
*Messrs. Metter and Moskowitz are the promoters of our company.
16
Michael Metter was was a principal of Security Capital Trading, a business
and marketing consultancy from 1998 to April, 2001. From April, 2001 to the
present, he has been president of RM Enterprises, Inc., our majority
stockholder, a company which also is the sole shareholder of Flo Weinberg
Originals, a designer and distributor of women's clothing. From 1994 to 1998, he
was President of First Cambridge Securities, a broker/dealer. From 1991 to 1994,
Mr. Metter was a Vice-President of the following broker/dealers: Royce
Investment Group; Gruntal & Company from 1990 to 1991; Commonwealth Associates
from 1989 to 1990; Prudential-Bache Securities from 1988 to 1989; of D.H. Blair
& Company, 1981 to 1989. Prior to 1981, Mr. Metter served as an independent
consultant and buyer for retail department stores. From 1983 to 1985, he was the
owner of Metter Broadcasting which operated four radio stations. Mr. Metter
received his MBA in Finance in 1975 and his B.A. in Marketing and Accounting in
1973 from Adelphi University.
Steven Moskowitz served as Vice President Marketing and Business
Development for H. W. Carter & Sons, a distributor of children's clothing, from
1997 to 2002. He was President of the H. W. Carter & Sons division of
Evolutions, Inc. from 1996 to 1997. Mr. Moskowitz served in various capacities
at Smart Style Industries, a manufacturer and distributor of ladies' apparel,
from 1986 to 1996 from sales assistant to Vice President Sales and Marketing. He
received his B.S. in Management from Touro College in 1986.
Jerome Schlanger has been Vice-President, Consulting, for NEMA Consulting
since 1987 a business management consultant. From 1977 to 1987, he served as
Executive Vice President and Chief Operating Officer of B.T. Inc. a developer of
residential real estate. He received his B.S. in Business Administration from
Villanova University in 1978.
Roger Eichenholtz served as an Independent Principal, International
Communications Management, Inc., a provider of accounting, management and
financial services, from April 1996 to August, 2002. He served as Vice President
Finance, Viva Optique, Inc., a manufacturer and distributor of opthalmics, from
March, 1993 to April, 1996. From February, 1992 to March, 1993, he was principal
of Eichenholtz Associates, a financial consultant to medium and small
businesses. Mr. Eichenholzt was Vice President-Finance & Chief Operating Officer
of Mitchell Apparel Group, a clothing manufacturer and distributor, from June,
1986 to February, 1992. From May, 1985 to June, 1986, he served as Vice
President - Finance, MBW Advertising Network, Inc., an advertising agency. He
was Chief Financial Officer, Intermaritime Forwarding Company, Inc. from
January, 1979 to April, 1985, an international freight forwarder and custom
house broker. From November, 1972 to December, 1978, Mr. Eichenholtz was
Controller and Chief Financial Officer of CBA Industries, Inc./Today Newspapers,
Inc., a publisher of a weekly shopping newspaper and a distributor of
advertising inserts, from November, 1972 to December, 1978 and from April, 1970
to November, 1972, Controller of Botany Industries, Inc., a cloting manufacturer
and retailer. He was Senior Accountant at Coopers & Lybrand, certifed public
accountants, from October, 1966 to March, 1970. Mr. Eichenholtz received his BBA
in Accounting & Finance from Pace University in 1966; his MBA in Finance from
Pace University in 1969.
Frank Lazauskas is the founder and President of FJL Enterpreises, Inc., and
TNJ Enterprises, Inc., formed in 1999 and 1997 respectively, which own and
operate eight Dominos Pizza Stores. From 1986 to 1997, Mr. Lazauskas was the
founder and President of FJL Pizza, Inc. which operated the stores. From 1983 to
1986, Mr. Lazauskas was employed by RPM Pizza, Inc., the franchisee of 300
Dominoes Pizza stores, in positions progressively as area superviser, regional
operations manager, regional vice president and regional president. He received
his B.A. in Mathematics from Central Connecticut State University in 1983.
17
Director Compensation
---------------------
Our directors do not receive cash compensation for their services as
directors but are reimbursed for their reasonable expenses for attending board
and board committee meetings. Our board of directors has not established any
committees.
Executive Compensation
----------------------
The following table sets forth for the fiscal years ended May 31, 2002 and
2001, the compensation we paid to our Chief Executive Officer(s) and any other
executive officers who earned in excess of $100,000 based on salary and bonus.
Summary Compensation Table
Long Term
Compensation
Annual Compensation Awards
====================================================================================================================
Other Annual Securities
Name and Principal Compensation Underlying
Position Year(1) Salary ($) Bonus ($) ($) Options/SARs (#)
====================================================================================================================
Michael Metter 05/31/02 -0- -0- -0- -0-
Chief Executive Officer 05/31/01 -0- -0- -0- -0-
Option Grants for the fiscal years ended May 31, 2002 and 2001
--------------------------------------------------------------
The following table sets forth information concerning the grant of stock
options to the named executive officer during the fiscal years ended May 31,
2002 and 2001.
Individual Grants
======================================================================================================================
Potential Realizable
Value at Assumed
Number of % of Total Annual Rates of
Shares Options Stock Price
Underlying Granted to Exercise Appreciation
Options Employees Price Per Expiration for Option Term
Name Granted in Year Share Date 5% 10%
======================================================================================================================
Michael Metter -0- -0-% - - - -
Aggregated Option Exercise for the fiscal years Ended May 31, 2002 and 2001 and
Fiscal Year-End Option Values
18
The following table sets forth information concerning the exercise of stock
options during the fiscal years ended May 31, 2002 and 2001 by the named
executive officer, and his options outstanding at the end of the transition
period.
======================================================================================================================
Aggregate Option/SAR Exercises in Transition Period and TP-End Option/SAR Values
======================================================================================================================
Number of Securities
Underlying Unexercised
Options/SARs at TPY-End Value of Unexercised In-
Shares (#) the Money Options/SARs
Acquired on Value =========================== at TP-End ($)
Name Exercise (#) Realized ($) Exercisable Unexercisable Exercisable Unexercisable
======================================================================================================================
Michael Metter -0- -0- -0- -0- -0-
======================================================================================================================
Indemnification of directors and executive officers and limitation of liability
------------------------------------------------------------------------------
Section 145 of the Delaware General Corporation Law authorizes a court to
award, or a corporation's board of directors to grant, indemnity to directors
and officers in terms sufficiently broad to permit such indemnification under
certain circumstances for liabilities (including reimbursement for expenses
incurred) arising under the Securities Act. As permitted by the Delaware General
Corporation Law, our amended certificate of incorporation includes a provision
that eliminates the personal liability of our directors for monetary damages for
breach of fiduciary duty as a director, except for liability (1) for any breach
of the director's duty of loyalty to our company or our stockholders, (2) for
acts or omissions not in good faith or that involve intentional misconduct or a
knowing violation of law, (3) under section 174 of the Delaware General
Corporation Law (regarding unlawful dividends and stock purchases) or (4) for
any transaction from which the director derived an improper personal benefit.
As permitted by the Delaware General Corporation Law, our Bylaws provide
that we are required to indemnify our directors and officers, consultants and
employees to the fullest extent permitted by the Delaware General Corporation
Law. Subject to certain very limited exceptions, we are required to advance
expenses, as incurred, in connection with a legal proceeding to the fullest
extent permitted by the Delaware General Corporation Law, subject to certain
very limited exceptions. The rights conferred in our bylaws are not exclusive.
We have not obtained directors' and officers' liability insurance.
19
CERTAIN RELATED PARTY TRANSACTIONS
We were incorporated in New York State on July 18, 1999 as Romantic Scents,
Inc. by RM Enterprises International, Inc. which was issued 5,000 shares
representing all our issued and outstanding capital stock. On July 15, 2002, we
entered into a stock purchase agreement with Nexgen Acquisitions VIII, Inc.
under which we became a wholly-owned subsidiary. Our sole stockholder, RM
Enterprises International, received 12,000,000 shares of Nexgen Acquisitions
VIII and became its majority stockholder in consideration of expense
reimbursement and provision of office space. In June, 2002, we issued 775,000
shares to Joel Pensley, Esq. for legal services, 100,000 shares to Sunburst
Partners, Inc. for consulting services and 100,000 shares to Renegade
Consulting, Inc., benefically owned by Joel Pensley, for consulting services.
The shares issued to Joel Pensley were for legal services in preparation of the
registration statement and all amendments. The consulting services to Renegade
Consulting and Sunburst have been performed.
On October 9, 2002, Nexgen Acquisitions VIII changed its name to Spongetech
Delivery Systems, Inc.
In September, 2002, the major stockholder of Nexgen Acquisitions VIII
transferred 2,000,000 shares to Robert Rubin, a beneficial owner of stock of RM
Enterprises, but not a control person of RM Enterpriese, 300,000 shares to
Eugene Dworkis, 200,000 to Maurice Horroch and 500,000 shares of Falcon Crest
Capital, Inc.
On June 12, 2001, our name was changed to RSI Enterprises, Inc. and on
October 2, 2002 to Spongetech International, Ltd. On December 16, 2002, we
changed our domicile to Delaware. On December 16, 2002, Spongetech Delivery
Systems, Inc., our parent company, merged with and into us so that we became the
surviving company. Immediately subsequent to the merger, we changed our name to
Spongetech Delivery Systems, Inc.
Michael Sorrentino, a stockholder of RM Enterprises International, has
loaned us $25,000 payble on demand. We are paying interest at the rate of 10%
per annum. Mr. Sorrentino has not demanded payment. RM Enterprises, our majority
stockholder, has loaned us $51,930.
We believe that these transactions were on terms as favorable as could have
been obtained from an unaffiliated third party. All future transactions we enter
into with our directors, executive officers and other affiliated persons will be
on terms no less favorable to us than can be obtained from an unaffiliated party
and will be approved by a majority of independent, disinterested members of our
board of directors, and who had access, at our expense, to our or independent
legal counsel.
20
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information with respect to
beneficial ownership of our common stock as of the date of the prospectus by
each stockholder known by us to be the beneficial owner of more than 5% of our
common stock, each of our directors and executive officers and all executive
officers and directors as a group.
Shares of Common Stock Beneficially Owned(1)(2)
-----------------------------------------------
Name Title Number Percent
------------------ --------------- ----------- -------
RM Enterprises International,
Ltd. (3) 12,000,000 63.2%
50 20th Street
Brooklyn, New York 11232
Nexgen Holdings, Inc. (4) 2,791,000 14.7%
410 Park Avenue
Ndw York, New York 10022
Rubin Family Irrevocable
Stock Trust (5) 2,555,568 13.5%
25 Highland Boulevard
Dix Hills, New York 11746
Michael Metter (6) President -0- -0-%
One Tinker Lane
Greenwich, CT 06830
Steven Moskowitz (7) Secretary -0- -0-%
50 20th Street
Brooklyn, New York 11232
Jerome Schlanger (8) Treasurer 985,314 5.2%
50 20th Street
Brooklyn, New York 11232
Frank Lazauskas (9) A Director 883,654 4.4%
51 Niagara Street
Newark, New Jersey 07105
Kenneth Hubbard (10) 985,314 5.2%
19 Booth Court
Millbrook, New York 12545
Carole Klein (11) 985,314 5.2%
18 Aspen Way
Morristown, New Jersey 07960
Roger Eichenholtz (12) 135,260 0.7%
50 20th Street
Brooklyn, New York 11232
Officers and Directors 2,004,228 10.5%
(5 persons)
--------------------
21
(1) Beneficial ownership is determined in accordance with the rules of the SEC
and generally includes voting or investment power with respect to
securities. Unless otherwise indicated below, the persons and entity named
in the table have sole voting and sole investment power with respect to all
shares beneficially owned, subject to community property laws where
applicable.
(2) The percentage of beneficial ownership is based on 18,985,000 shares of our
common stock outstanding as of the date of the prospectus.
(3) The control persons of RM Enterprises International, Ltd. are as follows:
Deborah Metter, The Mindy Moskowitz and Steven Moskowitz Trust, The Rubin
Family Irrevocable Stock Trust, Jerome and Madeline Schlanger, Frank
Lazauskas, Kenneth Hubbard and Carole Klein.
(4) The control person of Nexgen Holdings, Inc. is Guy Cohen.
(5) The beneficiaries of The Rubin Family Irrevocable Stock Trust are Linda
Rubin, Andrew Rubin and Lisa Rubin. The trust owns 2,000,000 shares of our
common stock and 4.623% of the capital stock of RM Enterprises.
(6) Deborah Metter, wife of Michael Metter, our President, is the beneficial
owner of 169,447 shares of our common stock representing 0.8% of our issued
and outstanding stock through her ownership of 1.41% of the capital stock
RM Enterprises. Michael Metter disclaims beneficial ownership of these
shares.
(7) The Mindy Moskowitz and Steven Moskowitz Trust for Mindy Moskowitz, Daniel
Moskowitz, Ilana Moskowits and Gitty Moskowitz is the beneficial owner of
1,591,598 shares of our common stock representing 6.7% of our issued and
outstanding stock through its ownership of 13.244% of the capital stock of
RM Enterprises. Steven Moskowitz, our Secretary, disclaims beneficial
ownership of these shares.
(8) Jerome and Madeline Schlanger, husband and wife, as joint tenants, own 8.2%
of the capital stock of RM Enterprises.
(9) Frank Lazauskas, a Director, owns 6.94% of the capital stock of RM
Enterprises.
(10) Kenneth Hubbard owns 8.2% of the capital stock of RM Enterprises.
(11) Carole Klein owns 8.2% of the capital stock of RM Enterprises.
(12) Roger Eichenholtz, an officer, owns 11.7% of the capital stock of RM
Enterprises.
22
DESCRIPTION OF SECURITIES
Common Stock
We are authorized to issue 50,000,000 shares of common stock, $.001 par
value per share, of which 18,985,000 shares are issued and outstanding as of the
date of the prospectus. Each outstanding share of common stock is entitled to
one vote, either in person or by proxy, on all matters that may be voted upon by
their holders at meetings of the stockholders.
Holders of our common stock (i) have equal ratable rights to dividends from
funds legally available therefore, if declared by our board of directors; (ii)
are entitled to share ratably in all of our assets available for distribution to
holders of common stock upon our liquidation, dissolution or winding up; (iii)
do not have preemptive, subscription or conversion rights, or redemption or
sinking fund provisions; and (iv) are entitled to one noncumulative vote per
share on all matters on which stockholders may vote at all meetings of our
stockholders. Cumulative voting for the election of directors is not provided
for in our amended certificate of incorporation, which means that the holders of
a majority of the shares voted can elect all of the directors then standing for
election.
Our certificate of incorporation provides that specified provisions may not
be repealed or amended except upon the affirmative vote of the holders of not
less than 2/3 of the outstanding stock entitled to vote. This provision would
enable the holders of more than 1/3 of our voting stock to prevent amendments to
the certificate of incorporation if they were favored by the holders of a
majority of the voting stock.
Preferred Stock
---------------
We may, subject to limitations prescribed by Delaware law, provide for the
issuance of up to 5,000,000 shares of our preferred stock in one or more series,
to establish from time to time the number of shares to be included in each such
series, to fix the rights, preferences and privileges of the shares of each
wholly unissued series and any qualifications, limitations or restrictions
thereon, and to increase or decrease the number of shares of any such series
(but not below the number of shares of such series then outstanding) without any
further vote or action by the stockholders. Our board of directors may authorize
the issuance of preferred stock with voting or conversion rights that could
adversely affect the voting power or other rights of the holders of our common
stock. The issuance of preferred stock, while providing flexibility in
connection with possible acquisitions and other corporate purposes, could, among
other things, have the effect of delaying, deferring or preventing a change in
control and may adversely affect the market price of the common stock and the
voting and other rights of the holders of common stock. We have no current plans
to issue any shares of preferred stock.
Reports to Stockholders
-----------------------
We intend to furnish our stockholders with annual reports containing
audited financial statements as soon as practicable after the end of each fiscal
year. Our fiscal year ends on May 31st.
Transfer Agent
--------------
We have appointed Olde Monmouth Stock Transfer Co. Inc., Atlantic
Highlands, New Jersey as transfer agent for our shares of common stock.
22
SELLING STOCKHOLDERS
We are registering 4,485,000 of the shares, which were owned by our
stockholders prior to the acquisition of the capital stock of Spongetech
International, Ltd. We will not receive any of the proceeds from sales of shares
offered under this prospectus.
All costs, expenses and fees in connection with the registration of the
selling stockholders' shares will be borne by us. All brokerage commissions, if
any, attributable to the sale of shares by selling stockholders will be borne by
selling stockholders.
The following table sets forth as of the date of the prospectus:
o the name of each selling stockholder;
o the number of selling stockholders;
o the aggregate number of shares owned by each selling stockholder; and
o the number of shares each member will own after the completion of the
offering made pursuant to the prospectus.
Shares Owned Prior Shares Owned After
Number of to the Offering the Offering
Shares --------------------- ------------------
Selling Stockholder Offered Number Percent Number Percent
-------------------- ----------- --------- ------- ------ -------
Shinya Araki 5,000 5,000 - -0- -0-%
Neil Foley 5,000 5,000 - -0- -0-%
Jean Geyer 10,000 10,000 - -0- -0-%
Emma Hass 8,000 8,000 - -0- -0-%
Melvin Koeller 5,000 5,000 - -0- -0-%
Malcom McGuire 10,000 10,000 - -0- -0-%
Sue Neil 8,000 8,000 - -0- -0-%
Kevin O'Hara 8,000 8,000 - -0- -0-%
Olson Jeweler 5,000 5,000 - -0- -0-%
Bettye Oustz 8,000 8,000 - -0- -0-%
Angelo Palmisano 5,000 5,000 - -0- -0-%
Linda Chadwick 5,000 5,000 - -0- -0-%
Carol Polevoy 8,000 8,000 - -0- -0-%
Philip Wong 8,000 8,000 - -0- -0-%
Neil Cox 8,000 8,000 - -0- -0-%
Richard Blundell 10,000 10,000 - -0- -0-%
Ken Heng 10,000 10,000 - -0- -0-%
Donna Lutsky 5,000 5,000 - -0- -0-%
Jay Lutsky 5,000 5,000 - -0- -0-%
Tanna Sessions 5,000 5,000 - -0- -0-%
Dean Sessions 5,000 5,000 - -0- -0-%
Patsy Sessions 5,000 5,000 - -0- -0-%
Michelle Brown 5,000 5,000 - -0- -0-%
James John 8,000 8,000 - -0- -0-%
Arden Amos 10,000 10,000 - -0- -0-%
Robert Sessions 5,000 5,000 - -0- -0-%
Robert Sonfield 10,000 10,000 - -0- -0-%
Margot Krimmel 10,000 10,000 - -0- -0-%
Bonnie Carol 10,000 10,000 - -0- -0-%
Max Krimmel 10,000 10,000 - -0- -0-%
Renegade Consulting 100,000 100,000 0.6% -0- -0-%
Sunburst Partners 100,000 100,000 0.6% -0- -0-%
Joel Pensley 775,000 775,000 4.1% -0- -0-%
Falcon Crest Capital,
Inc. 500,000 500,000 2.6% -0- -0-%
Nexgen Holdings, Inc. 2,791,000 2,791,000 14.7% -0- -0-%
410 Park Avenue
New York, NY 10022
Number of stockholders: 33
22
PLAN OF DISTRIBUTION OF SHARES OF EXISTING STOCKHOLDERS
The shares covered by this prospectus may be offered and sold from time to
time by the selling stockholders. The term "selling stockholders" includes
transferees or other successors-in-interest selling shares received after the
date of the prospectus from a selling stockholder as a gift, pledge, partnership
distribution or other non-sale related transfer. Selling stockholders will act
independently of us in making decisions with respect to the timing, manner and
size of each sale. Sales may be made on one or more exchanges or in the
over-the-counter market or otherwise, at prices and under terms then prevailing
or at prices related to the then current market price or in negotiated
transactions. Selling stockholders may sell their shares by one or more of, or a
combination of, the following methods:
o purchases by a broker-dealer as principal and resale by such broker-dealer
for its own account pursuant to the prospectus;
o ordinary brokerage transactions and transactions in which the broker
solicits purchasers;
o block trades in which the broker-dealer so engaged will attempt to sell the
shares as agent; and
o in privately negotiated transactions.
In addition, any shares that qualify for sale pursuant to Rule 144 may be
sold under Rule 144 rather than pursuant to the prospectus.
To the extent required, the prospectus may be amended or supplemented from
time to time to describe a specific plan of distribution. In connection with
distributions of the shares or otherwise, the selling stockholders may enter
into hedging transactions with broker-dealers or other financial institutions.
In connection with such transactions, broker-dealers or other financial
institutions may engage in short sales of the common stock in the course of
hedging the positions they assume with the selling stockholders. The selling
stockholders may also sell their common stock short and redeliver the shares to
close out such short positions. Selling stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions which
require the delivery to such broker-dealer or other financial institution of
shares offered by this prospectus, which shares such broker-dealer or other
financial institution may resell pursuant to the prospectus (as supplemented or
amended to reflect such transaction). Selling stockholders may also pledge
shares to a broker-dealer or other financial institution, and, upon a default,
such broker-dealer or other financial institution, may effect sales of the
pledged shares pursuant to this prospectus (as supplemented or amended to
reflect such transaction).
In effecting sales, broker-dealers or agents engaged by selling
stockholders may arrange for other broker-dealers to participate. Broker-dealers
or agents may receive commissions, discounts or concessions from the selling
stockholders in amount to be negotiated immediately prior to the sale.
In offering the shares covered by the prospectus, selling stockholders and
any broker-dealers who execute sales for the selling stockholders may be deemed
to be "underwriters" within the meaning of the Securities Act in connection with
such sales. Any profits realized by selling stockholders and the compensation of
any broker-dealer may be deemed to be underwriting discounts and commissions.
23
In order to comply with the securities laws of certain states, shares must
be sold in such jurisdictions only through registered or licensed brokers or
dealers. In addition, in certain states, shares may not be sold unless they have
been registered or qualified for sale in the applicable state or an exemption
from the registration or qualification requirement is available and is complied
with.
We have advised the selling stockholders that the anti-manipulation rules
of Regulation M under the Exchange Act may apply to sales of shares in the
market and to the activities of the selling stockholders and their affiliates.
In addition, we will make copies of this prospectus available to the selling
stockholders for the purpose of satisfying the prospectus delivery requirements
of the Securities Act. Selling stockholders may indemnify any broker-dealer
participating in transactions involving the sale of the shares against certain
liabilities, including liabilities arising under the Securities Act.
At the time a particular offer of shares is made, if required, a prospectus
supplement will be distributed that will set forth the number of shares being
offered and the terms of the offering, including the name of any underwriter,
dealer or agent, the purchase price paid by any underwriter, any discount,
commission and other item constituting compensation, any discount, commission or
concession allowed or reallowed or paid to any dealer, and the proposed selling
price to the public.
We have agreed to indemnify the selling stockholders against certain
liabilities, including certain liabilities under the Securities Act.
We have agreed with the selling stockholders to keep the registration
statement of which this prospectus constitutes a part effective until the
earlier of:
o such time as all of the shares covered by this prospectus have been
disposed of pursuant to and in accordance with the Registration
Statement or
o two years from the effective date of the registration statement.
STOCK PURCHASE AGREEMENT
The following table sets forth certain information as of the date of the
prospectus, with respect to Colebrook for whom we are registering the resale of
the shares we may sell to Colebrook in the stock purchase agreement. Colebrook
proposes selling all of its shares, in which case it would beneficially own no
shares after the offering. Colebrook is not currently an affiliate of ours, has
not had a material relationship with us during the past three years, and is not
affiliated with a registered broker-dealer. Colebrook is receiving no
compensation from us whatsoever whether or not in the nature of commissions,
warrants, options or termination fees.
Name Shares Owned Prior Shares to be Sold Shares to be Owned % Owned After
to the Offering in the Offering After the Offering the Offering (1)
--------------------- ------------------ ----------------- ------------------ ----------------
Colebrook, Inc. 4,000,000 (2)(3) 4,000,000 (2) -0- -0-%
------------------ ----------------- ------------------ ----------------
Totals 4,000,000 4,000,000 -0- -0-%
24
(1) Based on 18,985,000 shares of our common stock issued and outstanding as
of the date of the prospectus.
(2) Represents up to 4,000,000 shares of our common stock that we may sell to
Colebrook pursuant to the stock purchase agreement. Colebrook may not
purchase our shares pursuant to the stock purchase agreement if, as a
result of such purchase, it would own in excess of 9.9% of our issued and
outstanding shares of common stock; and it will not own beneficially more
than 9.9% of our outstanding common stock at any time. The President of
Colebrook is Jerry Rehrer.
(3) The number of shares sold to Colebrook at any time may not exceed that
number of our shares the average closing bid price of which for the five
days preceding our notice that we are selling shares is greater than
$50,000 and that when added to the current number of shares acquired by
Colebrook during the 61 days preceding the put date or when added to our
shares owned by Colebrook, would exceed 9.9% of the total number of shares
of our common stock outstanding.
(4) Colebrook does not own any shares of our common stock. It is obligated to
purchase common stock under the stock purchase agreement; it has no other
commitments or arrangements to purchase or sell any of our securities and
will receive no commissions, fees or warrants from us.
On December 26, 2002, we entered into a stock purchase agreement with
Colebrook. The stock purchase agreement entitles us to issue and sell up to $2
million of our common stock to Colebrook following the commencement of trading
of our common stock, in tranches not less than $25,000 not to exceed $50,000.
We may start selling our common stock after the date our common stock
commences to trade and continue for a two year period. For us to sell stock to
Colebrook, there must be an effective registration statement on file with the
SEC covering the resale to the public by Colebrook of any shares that it
acquires under the stock purchase agreement. Also, we must give Colebrook a one
trading day advance notice of the date on which we intend to sell stock. The
notice must indicate the number of shares of common stock we intend to sell to
Colebrook and the aggregate price of the shares we are selling.
We cannot issue additional shares to Colebrook that, when added to the
shares Colebrook owns will result in Colebrook holding over 9.9% of our
outstanding shares upon completion of the put.
Colebrook will pay us 70% of the market price for each share of our common
stock. Market price is defined as the average closing bid price of our common
stock during the five trading days preceding the date of the notice.
25
Limitations and conditions to our rights to sell stock
-------------------------------------------------------
Our ability to sell shares of our common stock, and Colebrook's
obligation to purchase the shares, is subject to the satisfaction of certain
conditions. These conditions, among others, include:
o we have satisfied all obligations under the stock purchase agreement;
o our common stock is quoted and traded on the O.T.C. Bulletin Board, or
listed on Nasdaq or an exchange;
o our representations and warranties in the stock purchase agreement are
accurate as of the date of each sale of our stock;
o we have reserved for issuance a sufficient number of shares of our
common stock to satisfy our obligations to issue our shares;
o the registration statement for the shares we will be issuing to
Colebrook is effective as of the each date on which we sell shares and
no stop order with respect to the registration statement is in effect;
o a minimum of seven trading days has passed from the date of the prior
sale before engaging a subsequent sale; and
o our trading volume averages at least 25,000 shares per day during the
five trading days preceding each notice to sell our shares.
Colebrook is not required to acquire and pay for any additional shares of
our common stock once it has acquired $2 million worth of our shares.
Additionally, Colebrook is not required to acquire and pay for any shares of
common stock with respect to any particular sale for which, between the date we
give advance notice of an intended sale and the date the particular sale closes:
o we announce or implement a stock split or combination of our common
stock;
o we pay a dividend on our common stock;
o we make a distribution of all or any portion of our assets or
evidences of indebtedness to the holders of our common stock; or
o we consummate a major transaction, such as a sale of all or
substantially all of our assets or a merger or tender or exchange
offer that results in a change in control.
We may not require Colebrook to purchase any shares if:
o we, or any of our directors or executive officers, have engaged in a
transaction or conduct related to us that resulted in:
o an SEC enforcement action, administrative proceeding or civil lawsuit;
or
o a civil judgment or criminal conviction or for any other offense that,
if prosecuted criminally, would constitute a felony under applicable
law;
o we file for bankruptcy or any other proceeding for the relief of
debtors; or
o we breach covenants contained in the stock purchase agreement.
26
Termination
-----------
We may terminate our right to initiate further sales of our stock or
terminate the stock purchase agreement at any time by providing Colebrook a
written notice of our intention to terminate. However, termination will not
affect any other rights or obligations we have concerning the stock purchase
agreement.
Right of Indemnification
------------------------
We have agreed to indemnify Colebrook from all liability and losses
resulting from any misrepresentations or breaches we make in connection with the
stock purchase agreement or the registration statement.
Effect on our Outstanding Common Stock
--------------------------------------
The issuance of common stock under the stock purchase agreement will not
affect the rights or privileges of existing holders of common stock except that
the issuance of shares will dilute the economic and voting interests of each
shareholder.
We cannot determine the exact number of shares of our common stock issuable
under the stock purchase agreement and the resulting dilution to our existing
shareholders, which will vary with the extent to which we utilize the stock
purchase agreement and the market price of our common stock. The potential
effects of any dilution on our existing shareholders include the significant
dilution of the current shareholders' economic and voting interests in us.
COLEBROOK'S PLAN OF DISTRIBUTION
Colebrook is free to offer and sell its shares of our common stock at such
times, in such manner and at such prices as it may determine on a best efforts
basis. The types of transactions in which the shares of our common stock are
sold may include transactions in the over-the-counter market (including block
transactions), negotiated transactions, or a combination of such methods of
sale. The sales will be at market prices prevailing at the time of sale or at
negotiated prices. Such transactions may or may not involve brokers or dealers.
Colebrook has advised us that it has not entered into any agreement,
understanding or arrangement with any broker-dealers regarding the sale of its
shares, and does not have a coordinating broker acting in connection with the
proposed sale of our common stock.
Colebrook may sell its shares directly to purchasers or to or through
broker-dealers, which may act as agents. These broker-dealers may receive
compensation in the form of discounts, concessions or commissions from the
selling shareholders. They may also receive compensation from the purchasers of
our common stock for whom such broker-dealers may act as agents.
Colebrook is an "underwriter" within the meaning of Section 2(a)(11) of the
Securities Act. Any commissions received by broker-dealers and any profit on the
resale of the shares of our common stock sold by them might be deemed to be
underwriting discounts or commissions. Colebrook may agree to indemnify
broker-dealers for transactions involving sales of our common stock against
certain liabilities, including liabilities arising under the Securities Act.
Because Colebrook is an underwriter within the meaning of Section 2(a)(11)
of the Securities Act, it will be subject to prospectus delivery requirements.
27
We have informed Colebrook that the anti-manipulation rules of the SEC,
including Regulation M promulgated under the Securities Exchange Act of 1934,
will apply to its sales in the market, and have provided them with a copy of
such rules and regulations.
Regulation M may limit the timing of purchases and sales of any of the
shares of our common stock by Colebrook and any other person distributing our
common stock. The anti-manipulation rules under the Securities Exchange Act may
apply to sales of shares of our common stock in the market and to the activities
of Colebrook and its affiliates. Furthermore, Regulation M of the Securities
Exchange Act may restrict the ability of any person engaged in the distribution
of shares of our common stock to engage in market-making activities with respect
to the particular shares of common stock being distributed for a period of up to
five business days prior to the commencement of such distribution. All of the
foregoing may affect the marketability of our common stock and the ability of
any person or entity to engage in market-making activities with respect to our
common stock.
Rules 101 and 102 of Regulation M under the Securities Exchange Act, among
other things, generally prohibit certain participants in a distribution from
bidding for or purchasing for an account in which the participant has a
beneficial interest, any of the securities that are the subject of the
distribution. Rule 104 of Regulation M provides that no person, directly or
indirectly, may stabilize, effect any syndicate covering transaction, or impose
a penalty bid in connection with an offering of any security in contravention of
the rule's provisions.
Colebrook may not rely upon Rule 144 for the sale of our common shares in
the open market since it is an underwriter within the meaning of Section
2(a)(11) of the Securities Act and the safe-harbor provided by Rule 144 is not
available to underwriters of our common stock.
We will pay all expenses in connection with the registration and sale of
the common stock by the selling security holders. Colebrook will pay all
commissions, transfer taxes and other expenses associated with their sales. The
shares offered hereby are being registered pursuant to our contractual
obligations, and we have agreed to pay the expenses of the preparation of this
prospectus.
We have agreed to indemnify and reimburse Colebrook against any losses,
claims, damages or liabilities to which they may become subject under the
Securities Act of 1933, the Securities Exchange Act of 1934, or any other
federal or state law, insofar as such losses arise out of or are based upon (i)
any untrue statement or alleged untrue statement of a material fact contained in
a registration statement, or (ii) the omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein
not misleading.
We believe that the securities purchase agreement complies with the
guidelines contained in the SEC's interpretative discussion on equity line
financings of April, 2001.
28
SHARES ELIGIBLE FOR FUTURE SALE
Upon the effectiveness of the registration statement, 4,485,000 shares of
common stock owned by our stockholders, will be freely tradable without
restriction under the Securities Act. None of these shares are held by our
"affiliates" as that term is defined in Rule 144 under the Securities Act. We
have outstanding 18,985,000 shares of our common stock.
Shares of our common stock held by affiliates will be eligible for sale in
the public market, subject to certain volume limitations and the expiration of
applicable holding periods under Rule 144 under the Securities Act. In general,
under Rule 144, persons who have beneficially owned restricted shares for at
least one year are entitled to sell within any three-month period a number of
shares which does not exceed the greater of 1% of the number of shares of common
stock then outstanding (which will equal approximately 189,850 shares) or the
average weekly trading volume of the common stock during the four calendar weeks
preceding the filing of a Form 144 with the SEC relating to sales of common
stock. Sales under Rule 144 are also subject to manner of sale provisions and
notice requirements and to the availability of current public information about
us. Under Rule 144(k), a person who has not been one of our affiliates at any
time during the three months preceding a sale, and who has beneficially owned
the shares proposed to be sold for at least two years, is entitled to sell such
shares without complying with the manner of sale, public information, volume
limitation or notice provisions of Rule 144.
We can offer no assurance that an active public market in our shares will
develop. Future sales of substantial amounts of our shares (including shares
issued upon exercise of outstanding options) in the public market could
adversely affect market prices prevailing from time to time and could impair our
ability to raise capital through the sale of our equity securities.
WHERE YOU CAN FIND MORE INFORMATION
We have not previously been required to comply with the reporting
requirements of the Securities Exchange Act. We have filed with the SEC a
registration statement on Form SB-2 to register the securities offered by the
prospectus. The prospectus is part of the registration statement, and, as
permitted by the SEC's rules, does not contain all of the information in the
registration statement. For further information about us and the securities
offered under the prospectus, you may refer to the registration statement and to
the exhibits and schedules filed as a part of the registration statement. You
can review the registration statement and its exhibits at the public reference
facility maintained by the SEC at Judiciary Plaza, Room 1024, 450 Fifth Street,
N.W., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further
information on the public reference facility. The registration statement is also
available electronically on the World Wide Web at http://www.sec.gov.
LEGAL PROCEEDINGS
We are not a party to nor are we aware of any existing, pending or
threatened lawsuits or other legal actions.
29
LEGAL MATTERS
Certain legal matters, including the legality of the issuance of the shares
of common stock offered herein, are being passed upon for us by our counsel,
Joel Pensley, Esq., 211 Schoolhouse Road, Norfolk, Connecticut 06058. Mr.
Pensley is the beneficial owner of 775,000 shares of our common stock; he is
also the beneficial owner of Renegade Consulting, Inc., the holder of 100,000
shares.
EXPERTS
Our financial statements for the years ended May 31, 2002 and 2001 have
been included herein and in the registration statement in reliance upon the
report of DDK & Company LLP, New York, New York, independent certified public
accountants, appearing elsewhere herein, and upon the authority of DDK & Company
LLP as experts in accounting and auditing.
30
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
CONSOLIDATED FINANCIAL STATEMENTS AND
INDEPENDENT AUDITORS' REPORT
SIX MONTHS ENDED NOVEMBER 30, 2002 (unaudited) AND 2001 (unaudited)
AND YEARs ENDED MAY 31, 2002 AND 2001
PAGE
----
INDEPENDENT AUDITORS' REPORT F-2
CONSOLIDATED FINANCIAL STATEMENTS
BALANCE SHEETS AS OF NOVEMBER 30, 2002 (unaudited)
AND MAY 31, 2002 F-3
STATEMENTS OF OPERATIONS - SIX MONTHS ENDED
NOVEMBER 30, 2002 (unaudited) AND 2001 (unaudited) AND
YEARS ENDED MAY 31, 2002 AND 2001 F-4
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIENCY) -
SIX MONTHS ENDED NOVEMBER 30, 2002 (unaudited) and YEARS
ENDED MAY 31, 2002 AND 2001 F-5
STATEMENTS OF CASH FLOWS - SIX MONTHS ENDED NOVEMBER 30, 2002
(unaudited) AND 2001 (unaudited) AND YEARS ENDED
MAY 31, 2002 AND 2001 F-6-7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS F-8-17
F-1
DDK & COMPANY, LLP
1500 Broadway
New York, New York 10036-4015
INDEPENDENT AUDITORS' REPORT
We have reviewed the consolidated balance sheet of Spongetech Delivery
Systems, Inc. and Subsidiary as of November 30, 2002, and the related
consolidated statements of operations, and cash flows for the six-month periods
ended November 30, 2002 and 2001. These financial statements are the
responsibilities of the company's management.
We conducted our review in accordance with standards established by the
American Institute of Certified Public Accountants. A review of interim
financial information consists principally of applying analytical procedures to
financial data and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, the objective of which is
the expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.
Based on our review, we are not aware of any material modifications that
should be made to the consolidated financial statements referred to above for
them to be in conformity with generally accepted accounting principles.
We have previously audited, in accordance with auditing standards generally
accepted in the United States of America, the consolidated balance sheet as of
May 31, 2002 and 2001, and the related consolidated statements of operations,
changes in shareholders' equity (deficiency), and cash flows for the years then
ended (not presented herein); and in our report dated August 15, 2002, we
expressed an unqualified opinion on those financial statements. In our opinion,
the information set forth in the accompanying consolidated balance sheet as of
May 31, 2002 is fairly stated in all material respects, in relation to the
consolidated balance sheet from which it has been derived.
March 14, 2003
New York, New York
F-2
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
November 30, May 31,
2002 2002
------------ --------
(unaudited)
ASSETS
Current Assets
Cash $ 3,171 $ 175
Accounts receivable 169 -
Inventories 47,586 49,357
Due from related parties 2,190 118
---------- ---------
Total current assets 53,116 49,650
Property and equipment, at cost,
less accumulated depreciation
of $16,150 and $9,218 as of November
30, 2002 and May 31, 2002, respectively 47,401 39,983
Deferred offering costs 19,000 -
---------- ---------
Total assets $ 119,517 $ 89,633
========== ==========
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY)
Current Liabilities
Accounts payable and accrued expenses $ 217,364 $ 158,865
Income taxes payable 1,600 400
Due to related parties 15,020 -
---------- ----------
Total current liabilities 233,984 159,265
Loans and note payable to related parties 80,570 79,320
---------- ----------
Total liabilities 314,554 238,585
---------- ----------
Shareholders' Equity (Deficiency)
Common stock, $.001 par value; authorized
50,000,000 shares; issued and outstanding
18,985,000 and 12,000,000 shares as of
November 30, 2002 and May 31,
2002, respectively 18,985 12,000
Preferred stock $.001 par value; authorized
5,000,000 hares; no shares issued and
outstanding - -
Additional paid-in capital 229,448 192,043
Deficit (443,470) (352,995)
----------- -----------
Total shareholders' equity (deficiency) (195,037) (148,952)
----------- -----------
Total liabilities and shareholders'
equity (deficiency) $ 119,517 $ 89,633
========== ==========
See notes to consolidated financial statements.
F-3
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
Six Months Ended
November 30, Year Ended May 31,
------------------------ --------------------
2002 2001 2002 2001
---------- ----------- ------- --------
(unaudited) (unaudited)
Sales $ 13,223 $ 33,887 $ 89,973 $ 11,790
Cost of goods sold 4,164 57,981 121,643 31,683
----------- ------------ ------------ -----------
Gross profit (loss) 9,059 (24,094) (31,670) (19,893)
----------- ------------ ------------ -----------
Operating expenses
Selling 1,781 13,202 15,982 50,416
General and administrative 94,707 39,637 51,711 127,034
Interest 2,646 1,360 2,714 547
----------- ------------ ------------ -----------
99,134 54,199 70,407 177,997
----------- ------------ ------------ -----------
Loss before provision for income
taxes (90,075) 78,293 (102,077) (197,890)
Income taxes 400 373 400 428
----------- ------------ ------------ -----------
Net loss $ (90,475) $ (78,666) $ (102,477) $ (198,318)
============ ============= ============ ===========
Basic and diluted (loss) per
common stock
Net loss per share -
basic and diluted $ (.01) $ (.01) $ (.01) $ (.02)
=========== ============ ============ ===========
Weighted average common
shares outstanding 17,267,377 12,000,000 12,000,000 12,000,000
=========== ============ ============ ===========
See notes to consolidated financial statements.
F-4
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(DEFICIENCY)
Six Months Ended November 30, 2002 (Unaudited)
and Years Ended May 31, 2002 and 2001
Total
Additional Shareholder's
Number of Capital Paid-In Equity
Shares Stock Capital Deficit (Deficiency)
--------- ------- ---------- ------- --------------
Balance - June 1, 2000 12,000,000 $ 12,000 $ - $ (52,200) $ (40,200)
Net loss for year ended
May 31, 2001 - - - (198,318) (198,318)
---------- ---------- --------- ------------ ------------
12,000,000 12,000 - (250,518) (238,518)
Contributions - - 105,100 - 105,100
---------- ---------- --------- ------------ ------------
Balance - May 31, 2001 12,000,000 12,000 105,100 (250,518) (133,418)
Net loss for year ended
May 31, 2002 - - - (102,477) (102,477)
---------- ---------- --------- ------------ ------------
12,000,000 12,000 105,100 (352,995) (235,895)
Contributions - - 86,943 - 86,943
---------- ---------- --------- ------------ ------------
Balance - May 31, 2002 12,000,000 12,000 192,043 (352,995) (148,952)
Issuance of common stock 6,985,000 6,985 (1,595) - 5,390
Value of services
contributed by officers - - 39,000 - 39,000
Net loss for six months
ended November 30,
2002 - - - (90,475) (90,475)
---------- ---------- --------- ------------ ------------
Balance - November 30,
2002 18,985,000 $ 18,985 $ 229,448 $ (443,470) $ (195,037)
========== ========== ========= ============ ============
See notes to consolidated financial statements.
F-5
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended
November 30, Year Ended May 31,
---------------- ------------------
2002 2001 2002 2001
------- ------ ------ ------
(unaudited) (unaudited)
Operating Activities
Net loss $ (90,475) $ (78,666) $ (102,477) $ (198,318)
Adjustments to reconcile net loss to
net cash provided by (used in)
operating activities
Value of contributed officer
compensation 39,000 - - -
Bad debts - - 13,909 -
Depreciation 6,932 4,153 8,308 1,241
Interest expense added to loan
principal 1,250 1,250 2,390 -
Changes in operating assets and
liabilities
Accounts receivable (169) - (13,909) 894
Inventories 1,771 (105,214) (47,164) 19,861
Prepaid expense and other
current assets - 259 259 (259)
Accounts payable and accrued
expenses 58,499 134,858 95,399 47,714
Income taxes payable 400 - - -
Due to related parties 15,138 - - 12,971
--------- ---------- -------- ---------
Net cash provided by (used in)
operating activities 32,346 (43,360) (43,285) (115,896)
--------- ---------- -------- ---------
Investing Activities
Acquisition of property and
equipment (14,350) (33,540) (33,540) (14,900)
--------- ---------- -------- ---------
Net cash used in investing
activities (14,350) (33,540) (33,540) (14,900)
--------- ---------- -------- ---------
Financing Activities
Proceeds of note payable - related
party - - - 25,000
Proceeds from additional paid-in
capital - 76,943 76,943 105,100
Deferred offering costs (15,000) - - -
--------- ---------- -------- ---------
Net cash provided by (used in)
financing activities (15,000) 76,943 76,943 130,100
--------- ---------- -------- ---------
See notes to consolidated financial statements.
F-6
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
Six Months Ended
November 30, Year Ended May 31,
2002 2001 2002 2001
(unaudited) (unaudited)
Net increase (decrease) in cash 2,996 43 118 (696)
Cash - beginning 175 57 57 753
Cash - end $ 3,171 $ 100 $ 175 $ 57
Supplemental Information
Interest paid $ 500 $ 110 $ 110 $ 547
Income taxes paid $ - $ - $ - $ -
Noncash Transactions
Assets abandoned $ - $ - $ - $ 1,991
Parent company debt
contributed to additional paid-in
capital $ - $ 10,000 $ 10,000 $ -
Issuance of common stock $ 5,390 $ - $ - $ -
See notes to consolidated financial statements.
F-7
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
1 - Summary of Significant Accounting Policies
Nature of Operations
Spongetech Delivery Systems, Inc. ("SDS"), formerly known as Nexgen
Acquisitions VIII, Inc., a Delaware corporation, was incorporated on
January 31, 2002. At May 31, 2002, SDS was inactive. On July 15, 2002, SDS
acquired all the outstanding shares of Spongetech International, Ltd.
("SIL") (formerly RSI Enterprises, Inc. and Romantic Scents, Inc.), a New
York corporation, incorporated (as Romantic Scents, Inc.) on July 18, 1999.
SIL has developed a line of hydrophilic polyurethane auto, bath, beauty,
and home applicators and has commenced distribution of its automotive
product.
Basis of Presentation / Going Concern
The consolidated financial statements have been prepared for purposes of
registration with the Securities and Exchange Commission ("SEC"). The
consolidated financial statements include the accounts of SDS, the
registrant, and its wholly-owned subsidiary SIL (collectively, "the
Company") with all significant intercompany accounts and transactions
eliminated, and have been prepared in conformity with accounting principles
generally accepted in the United States of America, which contemplates
continuation of the Company as a going concern. However, the Company has
sustained substantial operating losses in recent years, current liabilities
exceed current assets, and total liabilities exceed total assets. These
factors raise substantial doubt about the Company's ability to continue as
a going concern. The recovery of assets and continuation of future
operations are dependent upon the Company's ability to obtain additional
debt or equity financing and its ability to generate revenues sufficient to
continue pursuing its business purposes. The Company is actively pursuing
financing to fund future operations.
Interim Financial Information (Unaudited)
The interim financial statements of the Company as of November 30, 2002 and
for the six months ended November 30, 2002 and 2001, included herein, have
been prepared by the Company, without audit, pursuant to the rules and
regulations of the SEC. The unaudited interim financial statements include
all adjustments, consisting of normal recurring adjustments, considered
necessary for a fair presentation of the results for the interim periods
presented. Certain information and footnote disclosures normally included
in the financial statements prepared in accordance with generally accepted
accounting principles have been condensed or omitted pursuant to such rules
and regulations relating to interim financial statements. In the opinion of
management, the accompanying unaudited statements reflect all adjustments
necessary to present fairly the results of its operations and its cash
flows for the six months ended November 30, 2002 and 2001.
F-8
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
1 - Summary of Significant Accounting Policies (Continued)
Accounts Receivable
Accounts receivable have been adjusted for all known uncollectible
accounts.
Inventories
Finished products inventories are carried at cost, principally first-in,
first-out, but not in excess of market.
Property and Equipment
Property and equipment are carried at cost. Depreciation has been provided
using straight-line and accelerated methods over the estimated useful lives
of the assets. Repairs and maintenance are expensed as incurred, and
renewals and betterments are capitalized.
Deferred Income Taxes
The Company recognizes deferred income tax assets and liabilities for the
expected future income tax consequences of temporary differences between
the carrying amounts and the income tax bases of assets and liabilities and
the effect of future income tax planning strategies to reduce any deferred
income tax liability.
Use of Estimates
The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect certain reported
amounts and disclosures. Accordingly, actual results could differ from
those estimates.
Deferred Offering Costs
Deferred offering costs incurred by the Company in connection with the
proposed registration statement will be offset against additional paid-in
capital upon the completion of the registration, if successful, or charged
to operations if abandoned.
Advertising Costs
Advertising costs are expensed as incurred. For the years ended May 31,
2002 and 2001, advertising costs totaled $3,700 and $26,900, respectively.
For the six months ended November 30, 2002 and 2001, advertising costs
totaled $280 and $1,000, respectively.
F-9
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
1 - Summary of Significant Accounting Policies (Continued)
Shipping and Handling Costs
Shipping costs are included in selling expenses. For the years ended May
31, 2002 and 2001, shipping costs totaled $2,726 and $644, respectively.
For the six months ended November 30, 2002 and 2001, shipping costs totaled
$197 and $479, respectively.
Net Income (Loss) Per Share
Per share data has been computed and presented pursuant to the provisions
of SFAS No. 128, earnings per share. Net income (loss) per common share -
basic is calculated by dividing net income (loss) by the weighted average
number of common shares outstanding during the period. Net income (loss)
per common share - diluted is calculated by dividing net income (loss) by
the weighted average number of common shares and common equivalent shares
for stock options outstanding during the period.
Recent Accounting Pronouncements
New accounting statements issued, and adopted by the Company, include the
following:
In July 2001, the Financial Accounting Standards Board ("FASB") issued
Statement No. 141, "Business Combinations" ("SFAS 141"), which requires all
business combinations initiated after June 30, 2001 to be accounted for
using the purchase method of accounting. As a result, use of the
pooling-of-interests method is prohibited for business combinations
initiated thereafter. SFAS 141 also establishes criteria for the separate
recognition of intangible assets acquired in a business combination. The
adoption of SFAS 141 did not have a material impact on the Company's
consolidated results of operations, financial position or cash flows
In July 2001, the FASB issued Statement No. 142, "Goodwill and Other
Intangible Assets" ("SFAS 142"), which requires that goodwill and certain
other intangible assets having indefinite lives no longer be amortized to
earnings, but instead be subject to periodic testing for impairment.
Intangible assets determined to have definitive lives will continue to be
amortized over their useful lives. This Statement is effective for the
Company's 2003 fiscal year. However, goodwill and intangible assets
acquired after June 30, 2001 are subject immediately to the
non-amortization and amortization provisions of this Statement. The
adoption of SFAS 142 did not have an impact on the Company's consolidated
results of operations, financial position or cash flows.
F-10
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
1 - Summary of Significant Accounting Policies (Continued)
Recent Accounting Pronouncements (Continued)
In August 2001, the FASB issued Statement No. 143, "Accounting for Asset
Retirement Obligations" ("SFAS 143"), which provides the accounting
requirements for retirement obligations associated with tangible long-lived
assets. This Statement requires entities to record the fair value of a
liability for an asset retirement obligation in the period in which it is
incurred. This Statement is effective for the Company's 2003 fiscal year,
and early adoption is permitted. The adoption of SFAS 143 did not have a
material impact on the Company's consolidated results of operations,
financial position or cash flows.
In October 2001, the FASB issued Statement No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets" ("SFAS 144"), which excludes
from the definition of long-lived assets goodwill and other intangibles
that are not amortized in accordance with SFAS 142. SFAS 144 requires that
long-lived assets to be disposed of by sale be measured at the lower of
carrying amount or fair value less cost to sell, whether reported in
continuing operations or in discontinued operations. SFAS 144 also expands
the reporting of discontinued operations to include components of an entity
that have been or will be disposed of rather than limiting such
discontinuance to a segment of a business. This Statement is effective for
the Company's 2003 fiscal year, and early adoption is permitted. The
adoption of SFAS 144 did not have a material impact on the Company's
consolidated results of operations, financial position or cash flows.
In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements
No. 4, 44 and 64, Amendment of FASB Statement No. 13, and Technical
Corrections. Among other provisions, this Statement eliminates the
requirement that gains and losses from extinguishment of debt be classified
as extraordinary items. The Company will adopt SFAS 145 in fiscal 2003, and
has determined it will not impact the Company's consolidated financial
position, results of operations or cash flows.
In July 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated
with Exit or Disposal Activities. This Statement requires that a liability
for a cost associated with an exit or disposal activity be recognized when
the liability is incurred, rather than when a company commits to an exit
plan as was previously required. SFAS 146 is effective for exit or disposal
activities that are initiated after December 31, 2002. The Company will
adopt SFAS 146 in fiscal 2003, and has determined it will not impact the
Company's consolidated financial position, results of operations or cash
flows.
F-11
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
2 - Property and Equipment
Property and equipment is summarized as follows:
Estimated
Useful Lives November 30, May 31,
Years 2002 2002
------------ ------------ ---------
(unaudited)
Furniture and fixtures 5 - 7 $ 761 $ 761
Machinery and equipment 5 - 7 24,478 10,128
Molds 5 38,312 38,312
-------- --------
63,551 49,201
Less: Accumulated depreciation 16,150 9,218
-------- --------
$ 47,401 $ 39,983
======== ========
Depreciation expense for the years ended May 31, 2002 and 20001 was $8,308
and $1,241, respectively. Depreciation expense for the six months ended
November 30, 2002 and 2001 was $6,932 and $4,153, respectively.
3 - Stock Purchase Agreement / Initial Public Offering
On July 15, 2002, SDS entered into an agreement with RM Enterprises
International, Inc., a Delaware corporation, to acquire its wholly-owned
subsidiary SIL. On that date, SDS acquired all of the common stock of SIL
for 12,000,000 shares of its $.001 par value common stock. The transaction
was structured as a tax free exchange and was accounted for as a reverse
acquisition, using the purchase method of accounting.
On November 1, 2002, the Company filed a registration statement on Form
SB-2 with the Securities and Exchange Commission to register 2,791,000
shares for resale. The number of shares being registered was increased to
4,485,000 for resale by existing shareholders and 4,000,000 shares
underlying the securities purchase agreement (see note 10). The Company has
agreed to pay for all registration costs of the offering and will receive
no proceeds.
F-12
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
3 - Stock Purchase Agreement (Continued)
The following are the proforma financial statements as of May 31, 2002 and
for the year then ended:
May 31, 2002
RSI Nexgen
Enterprises, Acquisitions Proforma Proforma
Inc. VIII, Inc. Adjustments Combined
------------ ------------ ----------- -----------
ASSETS
Current Assets
Cash $ 175 $ - $ - $ 175
Inventories 49,357 - - 49,357
Due from affiliate - 2,190 - 2,190
Due from related parties 118 - - 118
----------- ---------- --------- -----------
Total current assets 49,650 2,190 - 51,840
Property, plant, and equipment, net 39,983 - - 39,983
----------- ---------- --------- -----------
Total assets $ 89,633 $ 2,190 $ - $ 91,823
=========== ========== ========= ============
LIABILITIES AND SHAREHOLDER'S EQUITY
(DEFICIENCY)
Current Liabilities
Accounts payable and accrued
expenses $ 158,865 $ - $ - $ 158,865
Income taxes payable 400 400 - 800
----------- ---------- --------- -----------
Total current liabilities 159,265 400 - 159,665
Loans and note payable to related
parties 79,320 - - 79,320
----------- ---------- --------- -----------
Total liabilities 238,585 400 - 238,985
----------- ---------- --------- -----------
Shareholders' Equity (Deficiency)
Common stock, stated at par value 12,000 6,010 - 18,010
Additional paid-in capital 192,043 1,971 (6,191) 187,823
Deficit (352,995) (6,191) 6,191 (352,995)
----------- ---------- --------- -----------
Total shareholders' equity
(deficiency) (148,952) 1,790 - (147,162)
----------- ---------- --------- -----------
Total liabilities and share-
holders' equity (deficiency) $ 89,633 $ 2,190 $ - $ 91,823
=========== ========== ========= ============
F-13
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
3 - Stock Purchase Agreement (Continued)
Year Ended May 31, 2002
RSI Nexgen
Enterprises, Acquisitions Proforma Proforma
Inc. VIII, Inc. Adjustments Combined
------------ ------------ ----------- ----------
Sales $ 89,973 $ - $ - $ 89,973
Cost of goods sold 121,643 - - 121,643
----------- -------- ------- -----------
Gross profit (loss) (31,670) - - (31,670)
----------- -------- ------- -----------
Operating expenses
Selling 15,982 - - 15,982
General and administrative 51,711 5,791 - 57,502
Interest 2,714 - - 2,714
----------- -------- ------- -----------
70,407 5,791 - 76,198
----------- -------- ------- -----------
Loss before provision for income taxes (102,077) (5,791) - (107,868)
Income taxes 400 400 - 800
----------- -------- ------- -----------
Net loss $ (102,477) $ (6,191) $ - $ (108,668)
=========== ========== ======= ===========
4 - Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consist of the following:
November 30, May 31,
2002 2002
------------ ----------
(unaudited)
Purchases $ 150,334 $ 112,018
American Express - charge card 20,222 19,622
Professional fees 41,730 22,748
Freight charges 2,994 3,394
Other 2,084 1,083
--------- ---------
$ 217,364 $ 158,865
========= =========
F-14
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
5 - Note Payable - Related Party
During the year ended May 31, 2001, a relative of one of the parent
company's shareholders loaned $25,000 to the Company. The note bears
interest at 10% per annum and is payable upon demand. However, the loan is
classified as a long-term obligation because it is not expected to be
repaid within one year. Related interest expense for the years ended May
31, 2002 and 2001 was $2,500 and $547, respectively, and for the six months
ended November 30, 2002 and 2001 was $1,250 and $640, respectively. At
November 30, 2002 and May 31, 2002, unpaid interest of $3,640 and $2,390,
respectively, has been added to the loan principal.
6 - Related Party Transactions
The Company shares its facility with other related businesses. Expenses
incurred in the operations of the facility, including rent, telephone, and
other office expenses, were allocated to the various businesses. The
allocations were based on usage. Management believes these allocations are
reasonable. At November 30, 2002 and May 31, 2002, the Company has a
non-interest bearing liability, aggregating $51,930, payable to one of
these related parties. At May 31, 2002, the related party agreed to extend
the maturity date to January 2004. Accordingly, this liability has been
reclassified as long-term debt.
During the quarter ended November 30, 2002, the related party advanced
approximately $23,000 to the Company to cover operating expenses, of which
approximately $15,000 is payable to the related party at November 30, 2002.
At May 31, 2001, the Company has a non-interest bearing liability to its
parent of $10,000, which was contributed to additional paid-in capital
during the year ended May 31, 2002.
7 - Additional Paid-in Capital
During the years ended May 31, 2002 and 2001, SIL's former parent
contributed $86,943 and $105,100, respectively, as additional paid-in
capital.
During the six months ended November 30, 2002, the Company recorded the
value of officer compensation aggregating $39,000. Such amount has been
treated as being contributed to additional paid-in capital.
F-15
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
8 - Deferred Income Taxes
At November 30, 2002 and May 31, 2002, the Company has approximately
$402,000 and $351,000, respectively, of net operating loss carryforwards
available, which expire in various years through May 31, 2022. The
significant component of the Company's deferred tax asset as of November
30, 2002 and May 31, 2002 is as follows:
November 30, May 31,
2002 2002
------------ -----------
(unaudited)
Non-Current
Net operating loss carryforwards $ 191,000 $ 158,000
Valuation allowance for deferred tax asset 191,000 158,000
--------- ---------
$ - $ -
========= =========
SFAS No. 109 requires a valuation allowance to be recorded when it is more
likely than not that some or all of the deferred tax asset will not be
realized. At November 30, 2002 and May 31, 2002, a valuation allowance for
the full amount of the net deferred tax asset was recorded.
The reconciliation of reported income tax expense (benefit) to the amount
of income tax expense that would result from applying domestic federal
income taxes at the statutory rate is as follows:
November 30, May 31,
2002 2002
------------ ----------
(unaudited)
Statutory federal income tax (benefit) $ (22,500) $ (35,000)
State and local income tax (benefit) -
net of federal benefit (7,700) (12,000)
Valuation allowance 30,200 47,000
---------- ---------
$ - $ -
========== ==========
SPONGETECH DELIVERY SYSTEMS, INC.
AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended May 31, 2002 and 2001 and
Six Months Ended November 30, 2002 (Unaudited) and 2001 (Unaudited)
9 - Commitments and Contingencies
Supply and License Agreements
In July 2001, the Company entered into a supply and requirement agreement
with Dicon Technologies ("Dicon"), a manufacturing company that has
technological know-how and patented and proprietary information relating to
hydrophilic foam materials (sponges) and their applications. The agreement,
which expires after six years provides for two renewal periods, requires
the Company to purchase all of their requirement from Dicon, and Dicon
grants exclusive worldwide rights to distribute the products. Minimum
annual purchase requirements are set forth in the agreement. The Company
has satisfied the minimum purchase requirement for the first year.
The Company and Dicon have also entered into an exclusive license agreement
for certain molded hydrophilic foam products which the Company helped
develop, with super absorbent polymer and detergent soaps and waxes used
for the cleaning and polishing of land, sea and transportation vehicles.
The term of the agreement is for the full life of any design patent, which
may be issued on the molded sponge design.
Employment Contracts
The Company is currently negotiating with two executives to establish
employment contracts. No terms of these negotiations have been disclosed.
10 - Subsequent Events
As part of a plan of recapitilization and funding, the Company undertook a
series of steps as follows:
On December 16,2002, SDS changed its domicile to Delaware by merging with
and into Spongetech Sub, Inc. Its parent, Spongetech Delivery Systems, Inc.
then merged with and into it so that Spongetech Sub, Inc. became the
surviving corporation. Spongetech Sub, Inc. then changed its name to
Spongetech Delivery Systems, Inc.
On December 26, 2002, Spongetech entered into a securities purchase
agreement. The agreement entitles Spongetech to issue up to $2 million of
its common stock from time to time, in blocks of between $25,000 to $50,000
each, at a price per share calculated by a formula based on Spongetech's
stock price. The securities purchase agreement terminates two years
following the effective date of the registration of the resale of the
shares. Proceeds of stock sales will be used for working capital.
WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION DIFFERENT FROM
THAT CONTAINED IN THIS PROSPECTUS. THE SELLING STOCKHOLDERS LISTED IN THIS
PROSPECTUS ARE OFFERING TO SELL, SHARES OF COMMON STOCK ONLY IN JURISDICTIONS
WHERE OFFERS AND SALES ARE PERMITTED.
Until --------, all dealers that effect transactions in these securities,
whether or not participating in this offering, may be required to deliver a
prospectus. This is in addition to the dealers' obligation to deliver a
prospectus when acting as underwriters and with respect to their unsold
allotments or subscriptions.
SPONGETECH DELIVERY SYSTEMS, INC.
4,485,000 SHARES OF COMMON STOCK
UP TO 4,000,000 SHARES OF COMMON STOCK
____________________
PROSPECTUS
____________________
-------- ----, 2003
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
The Delaware General Corporation Law provides for the indemnification of
the officers, directors and corporate employees and agents of Spongetech
Delivery Systems, Inc. (the "Registrant") under certain circumstances as
follows:
INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS; INSURANCE.
(a) A corporation may indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the corporation)
by reason of the fact that he is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of the
corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, against
expenses (including attorneys' fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by him in connection with such
action, suit or proceeding if he acted in good faith and in a manner he
reasonably believed to be in or not opposed to the best interests of the
corporation, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful. The termination of
any action, suit or proceeding by judgment, order, settlement, conviction,
or upon a plea of nolo contendere or its equivalent, shall not, of itself,
create a presumption that the person did not act in good faith and in a
manner which he reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal action or
proceeding, had reasonable cause to believe that his conduct was unlawful.
(b) A corporation may indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed
action or suit by or in the right of the corporation to procure a judgment
in its favor by reason of the fact that he is or was a director, officer,
employee or agent of the corporation, or is or was serving at the request
of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against
expenses (including attorneys' fees) actually and reasonably incurred by
him in connection with the defense or settlement of such action or suit if
he acted in good faith and in a manner he reasonably believed to be in or
not opposed to the best interests of the corporation and except that no
indemnification shall be made in respect of any claim, issue or matter as
to which such person shall have been adjudged to be liable to the
corporation unless and only to the extent that the Court of Chancery or the
court in which such action or suit was brought shall determine upon
application that, despite the adjudication of liability but in view of all
the circumstance of the case, such person is fairly and reasonably entitled
to indemnity for such expenses which the Court of Chancery or such court
shall deem proper.
(c) To the extent that a director, officer, employee or agent of a corporation
has been successful on the merits or otherwise in defense of any action,
suit or proceeding referred to in subsections (a) and (b) of this section,
or in defense of any claim, issue or matter therein, he shall be
indemnified against expenses (including attorney's fees) actually and
reasonably incurred by him in connection therewith.
II-1
(d) Any indemnification under subsections (a) and (b) of this section (unless
ordered by a court) shall be made by the corporation only as authorized in
the specific case upon a determination that indemnification of the
director, officer, employee or agent is proper in the circumstances because
he has met the applicable standard of conduct set forth in subsections (a)
and (b) of this section. Such determination shall be made (1) by the board
of directors by a majority vote of a quorum consisting of directors who
were not parties to such action, suit or proceeding, or (2) if such a
quorum is not obtainable, or, even if obtainable a quorum of disinterested
directors so directs, by independent legal counsel in a written opinion, or
(3) by the stockholders.
(e) Expenses incurred by an officer or director in defending any civil,
criminal, administrative or investigative action, suit or proceeding may be
paid by the corporation in advance of the final disposition of such action,
suit or proceeding upon receipt of an undertaking by or on behalf of such
director to repay such amount if it shall ultimately be determined that he
is not entitled to be indemnified by the corporation as authorized in this
section. Such expenses including attorneys' fees incurred by other
employees and agents may be so paid upon such terms and conditions, if any,
as the board of directors deems appropriate.
(f) The indemnification and advancement expenses provided by, or granted
pursuant to, the other subsections of this section shall not be deemed
exclusive of any other rights to which those seeking indemnification or
advancement expenses may be entitled under any by-law, agreement, vote of
stockholders or disinterested directors or otherwise, both as to action in
his official capacity and as to action in another capacity while holding
such office.
(g) A corporation shall have power to purchase and maintain insurance on behalf
of any person who is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against any liability asserted
against him and incurred by him in any such capacity or arising out of his
status as such, whether or not the corporation would have the power to
indemnify him against such liability under this section.
(h) For purposes of this Section, references to "the corporation" shall
include, in addition to the resulting corporation, any constituent
corporation (including any constituent of a constituent) absorbed in a
consolidation or merger which, if its separate existence had continued,
would have had power and authority to indemnify its directors, officers and
employees or agents so that any person who is or was a director, officer,
employee or agent of such constituent corporation, or is or was serving at
the request of such constituent corporation as a director, officer,
employee or agent of another corporation, partnership, joint venture, trust
or other enterprise, shall stand in the same position under this section
with respect to the resulting or surviving corporation as he would have
with respect to such constituent corporation as he would have with respect
to such constituent corporation if its separate existence had continued.
II-2
(i) For purposes of this section, references to "other enterprises" shall
include employee benefit plans; references to "fines" shall include any
excise taxes assessed on a person with respect to an employee benefit plan;
and references to "serving at the request of the corporation" shall include
any service as a director, officer, employee or agent of the corporation
which imposes duties on, or involves services by, such director, officer,
employee, or agent with respect to an employee benefit plan, its
participants, or beneficiaries; and a person who acted in good faith and in
a manner he reasonably believed to be in the interest of the participants
and beneficiaries of an employee benefit plan shall be deemed to have acted
in a manner "not opposed to the best interests of the corporation" as
referred to in this section.
(j) The indemnification and advancement of expenses provided by, or granted
pursuant to, this section shall, unless otherwise provided when authorized
or ratified, continue as to a person who has ceased to be a director,
officer, employee or agent and shall inure to the benefit of the heirs,
executors, and administrators of such person.
Articles Eighth and Ninth of the Registrant's certificate of incorporation
provide as follows:
EIGHTH
The personal liability of the directors of the Corporation is hereby
eliminated to the fullest extent permitted by the provisions of paragraph (7) of
subsection (b) of Section 102 of the Delaware General Corporation Law, as the
same may be amended and supplemented.
NINTH
The Corporation shall, to the fullest extent permitted by the provisions of
Section 145 of the Delaware General Corporation Law, as the same may be amended
and supplemented, indemnify any and all persons whom it shall have power to
indemnify under said section from and against any and all of the expenses,
liabilities or other matters referred to in or covered by said section, and the
indemnification provided for herein shall not be deemed exclusive of any other
rights to which those indemnified may be entitled under any by-law, agreement,
vote of stockholders or disinterested directors or otherwise, both as to action
in his official capacity and as to action In another capacity while holding such
office, and shall continue as to a person who has ceased to be a director,
officer, employee or agent and shall inure to the benefit of the heirs,
executors and administrators of such a person. The foregoing right of
indemnification shall in no way be exclusive of any other rights of
indemnification to which such person may be entitled under any by-law,
agreement, vote of stockholders or disinterested directors, or otherwise.
Article XII of the Registrant's by-laws provides as follows:
ARTICLE XII--INDEMNIFICATION OF DIRECTORS AND OFFICERS
1. Indemnification. The corporation shall indemnify any person who was or
is a party or is threatened to be made a party to any proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in the
right of the corporation) by reason of the fact that such person is or was a
director, trustee, officer, employee or agent of the corporation, or is or was
serving at the request of the corporation as a director, trustee, officer,
employee or agent of another corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorneys' fees), judgments, fines
II-3
and amounts paid in settlement actually and reasonably incurred by such person
in connection with such action, suit or proceeding if such person acted in good
faith and in a manner such person reasonably believed to be in or not opposed to
the best interests of the corporation, and with respect to any criminal action
or proceeding, had no reasonable cause to believe such person's conduct was
unlawful. The termination of any action, suit or proceeding by judgment, order,
settlement, conviction, or upon a plea of nolo contendere or its equivalent,
shall not, by itself, create a presumption that the person did not act in good
faith and in a manner which the person reasonably believed to be in or not
opposed to the best interest of the corporation, and with respect to any
criminal action or proceeding, had reasonable cause to believe that such
person's conduct was lawful.
2. Derivative Action. The corporation shall indemnify any person who was or
is a party or is threatened to be made a party to any threatened, pending or
completed action or suit by or in the right of the corporation to procure a
judgment in the corporation's favor by reason of the fact that such person is or
was a director, trustee, officer, employee or agent of the corporation, or is or
was serving at the request of the corporation as a director, trustee, officer,
employee or agent of any other corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorneys' fees), judgments, fines
and amounts paid in settlement actually and reasonably incurred by such person
in connection with such action, suit or proceeding if such person acted in good
faith and in a manner such person reasonably believed to be in or not opposed to
the best interests of the corporation; provided, however, that no
indemnification shall be made in respect of any claim, issue or matter as to
which such person shall have been adjudged to be liable for gross negligence or
willful misconduct in the performance of such person's duty to the corporation
unless and only to the extent that the court in which such action or suit was
brought shall determine upon application that, despite circumstances of the
case, such person is fairly and reasonably entitled to indemnity for such
expenses as such court shall deem proper. The termination of any action, suit or
proceeding by judgment, order, settlement, conviction, or upon a plea of nolo
contendere or its equivalent, shall not, by itself, create a presumption that
the person did not act in good faith and in a manner which the person reasonably
believed to be in or not opposed to the best interest of the corporation.
3. Successful Defense. To the extent that a director, trustee, officer,
employee or agent of the corporation has been successful, on the merits or
otherwise, in whole or in part, in defense of any action, suit or proceeding
referred to in paragraphs 1 and 2 above, or in defense of any claim, issue or
matter therein, such person shall be indemnified against expenses (including
attorneys' fees) actually and reasonably incurred by such person in connection
therewith.
4. Authorization. Any indemnification under paragraph 1 and 2 above (unless
ordered by a court) shall be made by the corporation only as authorized in the
specific case upon a determination that indemnification of the director,
trustee, officer, employee or agent is proper in the circumstances because such
person has met the applicable standard of conduct set forth in paragraph 1 and 2
above. Such determination shall be made (a) by the board of directors by a
majority vote of a quorum consisting of directors who were not parties to such
action, suit or proceeding, (b) by independent legal counsel (selected by one or
more of the directors, whether or not a quorum and whether or not disinterested)
in a written opinion, or (c) by the stockholders. Anyone making such a
determination under this paragraph 4 may determine that a person has met the
standards therein set forth as to some claims, issues or matters but not as to
others, and may reasonably prorate amounts to be paid as indemnification.
II-4
5. Advances. Expenses incurred in defending civil or criminal actions,
suits or proceedings shall be paid by the corporation, at any time or from time
to time in advance of the final disposition of such action, suit or proceeding
as authorized in the manner provided in paragraph 4 above upon receipt of an
undertaking by or on behalf of the director, trustee, officer, employee or agent
to repay such amount unless it shall ultimately be determined by the corporation
that the payment of expenses is authorized in this Section.
6. Nonexclusivity. The indemnification provided in this Section shall not
be deemed exclusive of any other rights to which those indemnified may be
entitled under any law, by-law, agreement, vote of stockholders or disinterested
director or otherwise, both as to action in such person's official capacity and
as to action in another capacity while holding such office, and shall continue
as to a person who has ceased to be a director, trustee, officer, employee or
agent and shall insure to the benefit of the heirs, executors, and
administrators of such a person.
7. Insurance. The Corporation shall have the power to purchase and maintain
insurance on behalf of any person who is or was a director, trustee, officer,
employee or agent of the corporation, or is or was serving at the request of the
corporation as a director, trustee, officer, employee or agent of any
corporation, partnership, joint venture, trust or other enterprise, against any
liability assessed against such person in any such capacity or arising out of
such person's status as such, whether or not the corporation would have the
power to indemnify such person against such liability.
8. "Corporation" Defined. For purpose of this action, references to the
"corporation" shall include, in addition to the corporation, any constituent
corporation (including any constituent of a constituent) absorbed in a
consolidation or merger which, if its separate existence had continued, would
have had the power and authority to indemnify its directors, trustees, officers,
employees or agents, so that any person who is or was a director, trustee,
officer, employee or agent of such of constituent corporation will be considered
as if such person was a director, trustee, officer, employee or agent of the
corporation.
ITEM 25. EXPENSES OF ISSUANCE AND DISTRIBUTION.
The other expenses paid or payable by the Registrant in connection with the
issuance and distribution of the securities being registered are estimated as
follows:
Securities and Exchange Commission Registration Fee............. $ 300
Legal Fees...................................................... 7,750*
Accounting Fees................................................. 20,000
Printing and Engraving.......................................... 1,000
Blue Sky Qualification Fees and Expenses........................ 1,000
Transfer Agent Fee.............................................. 1,000
Miscellaneous................................................... 1,000
--------
Total.................................................... $ 32,050
--------
* Counsel was issued 775,000 shares of common stock for legal services in
connection with the registration statement related legal matters.
===========
II-5
ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.
We were incorporated in New York State as Romantic Scents, Inc. on July 18,
1999.
On July 15, 2002, we entered into a stock purchase agreement with Nexgen
Acquisitions VIII, Inc. under which we became a wholly-owned subsidiary and our
sole stockholder, RM Enterprises International, received 12,000,000 shares of
Nexgen Acquisitions VIII, Inc. and became its majority stockholder.
Nexgen Acquisitions VIII, Inc. was formed on February 5, 2002. On April 24,
2002, it issued 5,791,000 shares of its common stock to Nexgen Holdings, Inc.,
in consideration of expense reimbursement and provision of office space. In
June, 2002, it issued 775,000 shares to Joel Pensley, Esq. for legal services,
100,000 shares to Sunburst Partners, Inc. for consulting services and 100,000
shares to Renegade Consulting, Inc., benefically owned by Joel Pensley, for
consulting services. These shares were valued at par of $.001 per share. In
June, 2002, it accepted subscriptions from 30 people at $.01 per share of an
aggregate of 219,000 shares.On October 9, 2002, the name of Nexgen Acquisitions
VIII was changed to Spongetech Delivery Systems, Inc.
On December 16, 2002, we changed our domicile to Delaware. On December 16,
2002, Spongetech Delivery Systems, Inc. merged with and into us so that we
became the surviving company. Immediately subsequent to the merger, we changed
our name to Spongetech Delivery Systems, Inc.
These securities were sold under the exemption from registration provided
by Section 4(2) of the Securities Act. Neither the Registrant nor any person
acting on its behalf offered or sold the securities by means of any form of
general solicitation or general advertising. All purchasers represented in
writing that they acquired the securities for their own accounts. A legend was
placed on the stock certificates stating that the securities have not been
registered under the Securities Act and cannot be sold or otherwise transferred
without an effective registration or an exemption therefrom.
ITEM 28. UNDERTAKINGS.
The Registrant undertakes:
(1) To file, during any period in which offers or sales are being made,
post-effective amendment to this registration statement (the
"Registration Statement"):
(i) To include any prospectus required by Section 10 (a) (3) of the
Securities Act of 1933 (the "Securities Act");
(ii) To reflect in the prospectus any facts or events arising after
the Effective Date of the Registration Statement (or the most
recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the
information set forth in the Registration Statement;
(iii)To include any material information with respect to the plan of
distribution not previously disclosed in the Registration
Statement or any material change to such information in this
registration statement, including (but not limited to) the
addition of an underwriter.
To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than 20% change in the maximum
aggregate offering price set forth in the "Calculation of Registration Fee"
table in the effective registration statement.
II-6
To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;
(2) That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be treated as
a new registration statement of the securities offered, and the
offering of the securities at that time to be the initial bona fide
offering thereof.
(3) To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the
termination of the offering.
Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers and controlling persons of the
Registrant pursuant to any provisions contained in its Certificate of
Incorporation, or by-laws, or otherwise, the Registrant has been advised that in
the opinion of the SEC such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the
payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
II-7
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, the
registrant certified that it has reasonable grounds to believe that it meets all
of the requirements of the filing on Form SB-2 and authorized the registration
statement to be signed on its behalf by the undersigned, in Brooklyn, New York.
SPONGETECH DELIVERY SYSTEMS, INC.
January 13, 2003 By: /s/ Michael Metter
----------------------------
Michael Metter
President,
Chief Executive Officer
January 13, 2003 By: /s/ Roger Eichenholtz
---------------------------
Roger Eichenholtz
Chief Financial Officer
Chief Accounting Officer
In accordance with the requirements of the Securities Act of 1933, the
registration statement was signed by the following persons in the capacities and
on the dates stated.
SIGNATURE TITLE DATED
------------------------- --------------------------- ------------------
/s/Michael Metter
---------------------
Michael Metter President January 13, 2003
Chief Executive Officer
and a Director
/s/Steven Moskowitz
---------------------
Steven Moskowitz Secretary and a Director January 13, 2003
/s/ Jerome Schlanger
---------------------
Jerome Schlanger Treasurer and a Director January 13, 2003
/s/Frank Lazauskas
---------------------
Frank Lazauskas A Director January 13, 2003
II-8
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
3.1 Certificate of Incorporation of Nexgen VIII, Inc.*
3.2 Certificate of Amendment of Nexgen VIII, Inc. changing name to
Spongetech Delivery Systems, Inc.*
3.3 By-Laws of Spongetech Delivery Systems, Inc.*
3.4 Certificate of Incorporation of Romantic Scents, Inc.
3.5 Certificate of Amendment changing name of Romantic Scents, Inc. to
RSI Enterprises, Inc.
3.7 Certificate of Amendment change name of RSI Enterprises, Inc. to
Spongetech Enterprises Internatioal, Inc.
3.6 Certificate of Incorporation of Merger Sub, Inc.
3.7 Merger Certificate between Spongetech Delivery Systems and Merger
Sub, Inc.
3.8 Merger Certificate between Spongetech Enterprises International, Inc.
and Merger Sub, Inc.
3.9 Certificate of Amendment Changing name of Merger Sub, Inc. to
Spongetech Delivery Systems, Inc.
4.1 Specimen Certificate of Common Stock*
5.1 Opinion of Counsel
10.1 Stock Purchase Agreement by and among Nexgen Acquisitions VIII,
Inc., RM Enterprises International, Inc. and RSI Enterprises, Inc.*
10.2 Stock Purchase Agreement by and between Spongetech Delivery Systems,
Inc. and Colebrook, Inc.
10.3 License Agreement dated July 1, 2001 with Dicon Technologies
10.4 Supply and Requirements Agreement dated July 1, 2001 with Dicon
Technologies
10.5 Manufacturer's Representative Agreement dated July 1, 2001 with Dicon
Technologies
23.1 Accountant's Consent
23.2 Counsel's Consent to Use Opinion*
------------------
* Previously filed as an exhibit to registration statement on Form SB-2 filed
November 1, 2002
II-9